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Abstract
Human retroviruses exert a high level of control over their own gene expression as well as that of 
their host cell. In addition to the structural genes {gag, po/and env), expressed by all retroviruses, 
human retroviruses also encode additional regulatory genes. One regulatory gene promotes 
transcription of the viral genome and modulates the expression of specific cellular genes. The 
second gene (expressed by HIV and HTLV viruses) regulates viral expression posttranscriptionally 
by overcoming the effect of c/s-acting negative elements present within the incompletely spliced 
mRNAs.
In the human T cell leukaemia virus type 1 (HTLV-I) retrovirus, the regulatory gene is known as rex. 
The binding of Rex protein to a sequence at the 3' end of viral mRNA, known as the Rex response 
element (RxRE) leads to removal of posttranscriptional repression. A sequence within the U5 
region of the 5' long term inal repeat (LTR) has previously been described as exerting 
posttranscriptional repression. This element was termed a c/s-repressive sequence (CRS).
This thesis describes the discovery of a novel c/s-repressive sequence present within the 3' LTR of 
HTLV-I, termed the "downstream negative element" or ONE. Its function is investigated and 
compared to that of the known CRS. Each repressive element is shown to partially block the 
nucleocytoplasmic transport of LTR transcribed mRNAs. Presence of both elements is seen to 
completely block transport. Deletion of both elements completely removes Rex dependency.
Also described is the discovery of a c/s-positive element within the murine leukaemia virus 
extended packaging sequence (psi+). The MLV psi+ is used to enhance the packaging efficiency 
of pseudotyped retroviruses. Presence of the MLV psi+ is shown to partially remove Rex 
dependency from CRS-containing mRNAs. The positive element is shown to be present within the 
3' term inal 312 bp of the MLV psi+ and to remove Rex-dependency by activating the 
nucleocytoplasmic transport of psi 312-containing mRNAs. This element was termed a constitutive 
transport element or "CTE", after showing the same mechanism of action as a small element from 
the Mason-Pfizer monkey virus (MPMV).
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• Human T Cell Leukaemia Virus Type 1 (HTLV-I)
HTLV-I linked Diseases
Advances in cell culture technology following the discovery of Interleukin 2 (IL-2) made the long 
term culturing of human T cells possible (Morgan et al. 1976, Ruscetti et al. 1977). HTLV-I was 
isolated from cultures of lymphoma patients' T cells four years later (Poiesz 1980a-Hb,1981 ; Yoshida 
et al. 1982a+b). The first human retrovirus had been discovered. Epidemiological evidence has 
shown a clear association between infection with the HTLV-I virus and the disease adult T cell 
leukaemia / Lymphoma (ATLL) (Robert-Guroff and Gallo 1983; Wong-Staal et al. 1983, Yoshida et 
al. 1984; Miyoshi eta l. 1981, Yamamoto eta l. 1982, Popovic e ta l. 1983; SchCipbach 1989).
HTLV-I is endemic in Southern Japan and the Caribbean, with some regions of Japan having as 
many as 16% of the local population infected. Clusters of HTLV-I associated malignancies have also 
been documented in Southeastern USA, Central and South America, the Middle East and India. 
Following infection with HTLV-I there ensues a lengthy incubation or latency period of between 20 
and 40 years before the onset of ATLL, which fewer than 1 % of HTLV-I infected individuals actually 
go on to develop. Once ATLL is diagnosed, the disease progresses rapidly, patients having a 
median survival time of less than 12 months. As well as acute ATLL, some patients have a subacute 
or chronic disease. The subacute phase is characterized by >5% abnormal T cells in the peripheral 
blood and normal lymphocyte count. Elevated lymphocyte count (> 4 x 10^ / L) and serum LDH 
levels up to 200% of normal mark the onset of chronic ATL. Acute and lymphoma type ATL have a 
poor prognosis. ATL lymphoma patients have fewer than 1% abnormal lymphocytes and no 
lymphocytosis together with histologically-proven lymphadenopathy. The remaining patients are 
characterized as acute ATL, usually having tumour lesions but not satisfying the other three 
requirements (Shimoyama eta l. 1991). HTLV-I infection has also been associated with diseases of 
the central nervous system (CNS). Tropical spastic paraparesis (TSF) and HTLV-I associated 
myelopathy (HAM) may develop only a few years after infection with HTLV-I. Whereas ATL results in 
a monoclonal expansion of T cells, TSP/HAM patients have a polyclonal population with multiple 
integration sites w ithin the host genome (Osame et al. 1987). TSP/HAM results in the 
demyelination of nervous tissue. HTLV-I could also be linked to unexplained facial nerve palsy, 
rhombencephalitis and transverse myelopathy (Bartholomew e ta l. 1987; Gessain e ta l. 1986; 
Roman etal. 1987; DeFreitas eta l. 1987).
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Organization of the HTLV-I Retroviral Genome
HTLV-I like all other retroviruses expresses the three structural genes gag, pol and env. The gag 
gene (encoding p19 matrix-, p24 capsid- and p15 nucleocapsid proteins) and pol gene (encoding 
the reverse transcriptase, integrase and RNase H enzymes) are expressed from the full length 
genomic transcript with the env  gene requiring a single splicing event. The protease (pro) gene is 
situated between the gag and pol genes and is expressed via a ribosomal frameshift (-1). As well as 
these structural genes, HTLV-I also encodes five regulatory genes (p40fax ,p27rex, p12^ , p30^^ 
and p21 ^^^ ). The Tax and Rex proteins are expressed from two different reading frames after a 
second splicing event which involves the use of a splice donor (SD2 ) site just inside the env  gene 
and a splice acceptor (SA2 ) site inside the pX region. It has been shown that the p i 2 ^ and p30^^ 
gene products can be made via cryptic splicing into bp 6383 (SA3 ) and 6478 (SA4 ), respectively. 
These genes were termed rofand  to f (Ciminale eta l.  1992, 1995). p21^^^^ is transcribed from an 
AUG within the rex  reading frame. It is normally not expressed and has been suggested to 
antagonize Rex function. More recently it has been shown that deletion of the pX region between 
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Figure 1. Genome organization of H T L V -I. Expression of Open Reading Frames (ORFs) from 
unspliced, single-spliced and double-spliced HTLV-I transcripts.
Packaging and formation of infectious virus particles requires that unspliced genomic transcripts 
and singly spliced env  transcripts are able to leave the nucleus. A sequence mediating the 
packaging of HTLV-I genomic transcripts has not yet been identified as it is only recently that an 
infectious viral clone has been isolated (Derse et al. 1995, 1996; Zhao et al. 1995, 1996). The
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original HTLV-I clone, which was sequenced by Seiki et al. (1983) was later shown to be non- 
infectious.
In contrast to the more simple retroviruses, human retroviruses have evolved to better regulate their 
gene expression once integrated in the host genome. The HTLV tax and rex gene products are 
responsible for trans-activation of the HTLV-I LTR and promotion of intron-containing structural 
gene expression, respectively.
• Organization of the Long Terminal Repeat (LTR)
HTLV (Human T cell Leukaemia Virus) and HIV (Human Immunodeficiency Virus) are the most 
intensively investigated retroviruses to date, not only in connection with their associated diseases, 
but also with relation to their regulation of viral gene expression.
The HTLV LTR shows well defined regulation at multiple levels. Although the LTR is present twice 
in the viral genome (once at each end) the regulatory elements are only active in either one LTR or 
the other.
T A T A
6 0 0 i > U 5U 3 < J
C A P
T R E
Rex binding  
loop
CRSBasal
T Rex R E} ^  E = l  (GT)n ——  HRTRflfl c = = l - ^
Stem A  stem  A '
Figure 2: H T L V -I LTR  elements required for regulation of gene expression.
Active in the 5' LTR
At the beginning of the U3-region is a 4bp consensus sequence which is cleaved specifically prior 
to integration of the provirus in to the host chromosome. This is the upstream Integration site.
Inside the U3-region are situated the enhancer elements, the most important of which are known as 
the Tax response element (TRE). This consists of three 21 bp repeats which can bind cAMP 
response element binding (CREB) proteins, following their interaction with the HTLV trans- 
activation protein Tax. Tax frans-activation of the LTR promoter results in a pulse of viral gene 
expression.
The viral promoter (TATA box) is situated just upstream of the U3/R boundary and is responsible for 
expression of all HTLV genes {gag,pol,env,pro,tax an6 rex). At the R/U5 boundary is a region
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known as the CAS (c/s-activating sequence). This is required for basal expression, in the absence 
of tax (Kashanchi eta l. 1993). In the U5 region is the CRS (c/s-repressive sequence) which appears 
to reduce expression from the LTR promoter. Part of this repression may be due to a block in 
transport of unspliced viral transcripts {gag and pol) - which encode this sequence within their 5' 
non-translated region (NTR) - from the nucleus to the cytoplasm (Seiki et al. 1990). At least in 
HTLV-I I, the CRS inhibition is overcome by rex function (Black eta l. 1991).
Active in the 3' LTR
The entire R region encodes a structure known as the Rex response element (RxRE). This high 
energy secondary structure is formed and stabilized by a main stem derived from sequences at the 
boundaries of the U3/R and R/U5 regions. This RNA secondary structure serves two purposes:
a. Formation of the polyadenylation motif
For correct polyadenylation, the poly A signal (AATAAA) and the GU-rich poly A site must 
be in close proximity. Formation of the RxRE (fig.2, stems A and A') brings these two 
regions, which are 255 nucleotides apart, in juxtaposition.
b. Formation of the Rex-binding motif (Bogard eta l. 1992)
The HTLV regulatory protein - Rex - binds to a motif created in the RxRE . Rex binding 
has been linked to promotion of transport of unspliced {gag - pol) and single spliced {env) 
viral transcripts.
At the end of the U5 region is the second 4bp consensus sequence constituting the downstream 
proviral integration site.
• Gene Expression - Regulation by Tax and Rex
Upon entering the host cell, the two single-stranded RNA molecules that constitute the HTLV 
genome are reverse transcribed into DNA. This proviral DNA then integrates randomly into the host 
genome where it’s transcription can be activated by the action of Tax and the host’s transcription 
machinery.
Tax frans-activates the HTLV-I promoter indirectly by interacting with and/or enhancing the binding 
of members of the CREB protein family (TREB 1,2,3,5,17; ) to the imperfect 21 bp repeats within 
the U3 enhancer region (Beimling et al. 1992, Suzuki eta l. 1993). This region is known as the Tax 
response element (TRE). Tax has also been shown to frans-activate cellular genes such as 
interleukin 2  receptor alpha, granulocyte-macrophage colony-stimulating factor, fos, jun, myc, sis 
and MHO class I (Inoue eta l. 1986, Maruyama eta l. 1987, Alexandre and Verrier 1991, Fujii eta l.
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1991, Mirai et al. 1992, Mimes et al. 1993). The diversity of Tax function upon cellular genes is partly 
due to its interaction with the NFkB/Rel family of proteins (Paul et al. 1993, Beraud et al. 1994, 
Lacoste eta l. 1995).
Before strong Tax frans-activation can occur. Tax must be expressed. This could be achieved via 
two different mechanisms. Firstly, the U3 enhancer region contains binding sites for a variety of 
cellular factors. An increase in the binding of these factors would very quickly lead to a Tax- 
mediated amplification and a wave of MTLV-I gene expression. The alternative is that Tax is initially 
expressed from an Internal promoter/enhancer element between the translation start sites (ATG) for 
rex and fax (Nosaka eta l. 1993). Once Tax-induced transcription from the S' LTR has been initiated, 
all transcripts are efficiently double-spliced, removing the two regions spanning from the middle of 
the R region (S' LTR) to the beginning of the env gene (splice 1) and from a splice donor just inside 
the env  gene to a splice acceptor in the pX-region (splice 2). These transcripts, which are 
expressed independently of Rex function, encode the Tax and Rex proteins from two different 
reading frames. The export of unspliced and partially spliced transcripts is promoted by the Rex 
protein, which also functions to downregulate the expression of Tax and Rex genes, presumably 
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Figure 3. Regulation of H T L V -I gene expression by Tax and Rex.
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The exact mechanism of Rex function has been difficult to dissect experimentally. Rex has been 
shown to bind to the highly organized Rex response element (RxRE) structure, present at the 3' 
end of all HTLV-I transcripts and lead to the posttranscriptional promotion of structural gene 
expression (Grassmann et al. 1991, Inoue et al. 1987). The observation that these incompletely 
spliced transcripts were frans-regulated by Rex only if they had a splice donor site suggested that 
Rex was functioning by interfering with the cellular splicing machinary (Seiki et al. 1988). Hidaka et 
al. (1988) showed that Rex expression led to an increase in incompletely spliced {gag-pol an6 env) 
gene expression and a suppression of completely spliced (fax and rex) gene expression. It was also 
shown that Rex expression led to an increase in unspliced RNA in the nucleus as well as in the 
cytoplasm (Inoue etal. 1991). The alternative hypothesis is that unspliced transcripts are retained in 
the nucleus due to the presence of c/s-repressive sequences (CRS) and thus subjected to splicing 
and other nuclear processes. In this situation Rex binding would signal the export of the intron- 
containing transcripts. A CRS sequence has been identified within the HTLV-I 5' LTR U5 region 
(Seiki et al. 1990). In HTLV-II, Rex has been shown to be important in overcoming the CRS- 
mediated transport block, through binding the RxRE (Black etal. 1991).
• Expression of Two Genes in Cis - the Double Copy Vectors
There are a number of different strategies for expressing two or more genes in eukaryotic cells. The 
first strategy is to use an "internal promoter" (Wagner eta l. 1985). For this a second promoter and 
second gene are cloned downstream of the first gene (fig. 4A). The second strategy is to introduce 
a 3' splice site (splice acceptor) between the two genes. This allows the two genes to be expressed 
from spliced and unspliced transcripts by the LTR promoter (fig. 4B). The third strategy involves the 
use of an "internal ribosome entry signal" (1RES) between the two genes (fig. 4C). This enables 
ribosomes to join the mRNA directly at the 1RES instead of at the cap site (Jang et al. 1990a-hb, 
Ghattas eta l. 1991). Internal ribosome entry allows the expression of two genes from one promoter 
on the same mRNA molecule. All three strategies have been shown to work, however, none of 
them work in all situations. The internal promoter vectors are often prone to promoter silencing 
(Emerman and Temin 1986, Nakajima eta l. 1993), meaning that the upstream promoter becomes 
more active than the downstream one, in some cases the downstream gene is no longer 
expressed. The splicing vectors do not always work because for efficient expression of both genes 
it is important to have inefficient splicing so that the first gene has a chance of being expressed. 
Because the efficiency of splicing not only depends on the sequence of the 3' splice signal but 
also upon signals present within the intron as well as the size of the intron itself, it has been difficult 
to design splice vectors that express both genes efficiently (Dougherty and Temin 1986). The 
1RES vectors offer a very attractive mechanism for expressing two genes, however, for reasons 
unknown the first gene is usually expressed preferentially.
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Figure 4. Different strategies for expression of two genes from a retroviral vector.
The double-copy (DC) vector was initially designed for higher expression of a single gene. Instead 
of cloning a gene between the two LTRs, a gene was cloned (with its own promoter) inside the U3 
region of the 3' LTR. During reverse transcription of the viral genome, the U3 region of the 3' LTR is 
copied over to the 5' LTR. The resulting integrated proviral genome thus contains two copies of the 
inserted gene, one inside each of the LTRs. Stuhlmann et al. (1989) used a DC vector to express 
the dihydrofolate reductase (DHFR) gene. The development of high titer infectious virus showed 
that the U3 region insertions did not significantly interfere with viral replication. Hantzopoulos et ai. 
(1989) also used an MLV based DC vector. This was used to express an ADA (adenosine 
deaminase) minigene. It was shown that insertion of the ADA minigene into the U3 region resulted 
in a 10-20 fold increase in the number of transcripts produced and human ADA isozyme 
synthesized in NIH 3T3 cells, compared to insertion of the minigene between the two LTRs. It was 
hoped that DC vectors would be more resistant to the gene silencing phenomenon observed 
following transduction of cells in vitro and in vivo.
• Posttranscriptional Regulation in Human immunodefficiency Virus type 1
In 1984, a virus was isolated from a patient with lymphadenopathy syndrome (LAS) (Barré-Sinoussi 
et ai. 1983) - a disease known to progress to acquired immune deficiency syndrome (AIDS). As 
initial sequence comparisons showed homologies to the HTL viruses, the virus was initially termed 
HTLV-III. Following the complete sequencing of HTLV-I (Seiki et ai. 1983) and characterization of a 
number of different HTLV-III isolates (Gallo et ai. 1984; Levy et ai. 1984; Popovic et ai. 1984;
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Sarngadharan eta l. 1984; Schüpbach et al. 1984a+b; Vilmer eta l. 1984), HTLV-III was re-named 
Human Immunodeficiency Virus type 1 (HIV-1) (Coffin et al. 1986).
DNA sequencing of the first HTLV-I clone by Seiki eta l. (1983) opened the door to a vast amount of 
information which later proved invaluable for workers in the HIV field. Although the two viruses 
share almost no sequence identity, the organization of the viral genomes and mechanisms of 
expression regulation are so similar that HTLV-I studies foreshadowed many important HIV 
discoveries made up until 1990.
The HTLV regulatory genes known as tax and rex (Kiyokawa et al. 1984,1985) were discovered 
first. The HIV equivalents faf and rev were then identified in 1985 (Arya et al.) and 1986 (Sodroski et 
al.), respectively.
HIV Rev was also shown to be required for HIV structural gene expression (Knight e ta l. 1987). In 
1989 Hadzopoulou-Cladaras etal. and Malim eta l. identified a Rev response element (RRE) within 
the env open reading frame. Rev binding to the RRE resulted in expression of the gag  and env 
transcripts which had been shown to contain sequences that "contribute to low levels of mRNA 
accumulation". Interestingly, the HIV RRE is present only in structural gene mRNAs, whereas the 
HTLV-I RxRE is present at the end of all viral mRNAs. As in the case of Rex, HIV Rev has also been 
implicated in multiple regulation mechanisms. The observation that Rev expression also results in 
an increase in spliced mRNA and a decrease in unspliced mRNA hinted to an interaction with the 
cellular splicing machinery. It was shown that interaction of Rev with the U lsnRNP (which binds 5' 
splice sites to initiate splicing) led to abrogation of splicing through blocking the association of 
U4/U6 and U5 snRNPs (Kjems etal. 1991,1993).
The observation that cells not expressing Rev often contained incompletely spliced viral mRNAs in 
their cytosols hinted that Rev was able to release a blockage existing at the translational level. Arrigo 
e ta l. (1991) showed that Rev expression resulted in polysomal association of these incompletely 
spliced cytoplasmic mRNAs. Rev was shown to directly promote the nuclear export of RRE 
containing mRNAs from Xenopus oocyte nuclei (Fischer eta l. 1994).
Following experiments which showed that Rex could substitute for Rev function (Rimsky et al. 
1988) and that domain exchanges between Rex and Rev were functional (Hope et al. 1991), efforts 
were made to identify the repressive elements present in the HIV structural transcripts.
Cochraine et al. (1991) identified a 260 nt region of the HIV po l RNA which appeared to be 
preventing the unspliced mRNAs from being translated. Schwartz et al. (1992a) identified a 218 nt 
AU - rich region of the HIV gag gene which destabilized grap-po/transcripts in the absence of Rev 
protein. The same authors also demonstrated that through introduction of 28 point mutations into 
the destabilizing region, the negative effect upon expression was removed (Schwartz et al. 1992b). 
HIV env consists of two glycoproteins termed gp41 and gp120. The env hetrodimer is termed 
gp160. In 1994 Brighty and Rosenberg identified a negative element within the RRE of gp41. 
Upon removal of the 240 bp RRE, resulting transcripts were no longer Rev-dependent. Also in
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1994, Nasioulas et al. identified an additional CRS element, inside tfie HIV env gene, but this time 
within the gp l 20 coding region. They reported that this CRS was functional in human cells but not 
in Drosophila  cells. This supported the observation that Rev is required for gp160- but not for 
gp120 expression in Drosophila cells (Ivey-hoyle and Rosenberg 1990). The gp120 CRS functions 
only in human cells, whereas the gp41 CRS (RRE) is thus functional in both human and Drosophila 
cells. This was the first evidence that a CRS element could be cell type specific.
Taken together, there is evidence that both HIV Rev and HTLV Rex are able to influence the 
expression of specific RNA species at different stages by overcoming the effect of various c/s- 
repressive signals. It is possible that the different CRS elements are able to bind specific cellular 
factors which then inhibit the transcript's expression via different mechanisms.
• Protein and RNA Transport through the Nuclear Pore Complex (NPC)
It was once assumed that gene expression was controlled only at the transcription stage and that 
transcribed RNAs were able to diffuse passively through pores of the nuclear membrane into the 
cytoplasm. Examination of the nuclear pore complex (NPC) revealed that associated with the eight- 
multidomain pore are many protein factors. These were divided into two groups, the peripheral 
membrane proteins or "nucleoporins" and the integral NPC proteins. Three dimentional analysis 
suggests that only small molecules (<9 nm diametre) would be able to diffuse through the pore 
complex. Transport was shown to be an energy-dependent, carrier-mediated process (Zasloff 
1983, Khanna-Gupta e ta l. 1989, Guddat e ta l. 1990, Dargemont e ta l. 1992, Dingwall and Laskey 
1991).
Dividing Hela cells must synthesize 10 million ribosomes each day. This process alone demands 
that each nuclear pore is able to transport 100 ribosomal proteins and 3 ribosomal subunits within 
60 seconds (Gorlich and Mattaj 1996). The energy for this transport process comes (at least in part) 
from the guanosine triphosphatase (GTPase) "Ran". Ran is associated with two other proteins 
which enable it to hydrolyse GTP and exchange the associated GDP for a new GTP molecule. Until 
now, the only Ran activating factor discovered has been the cytoplasmic RNA 1 gene product. The 
nuclear RCC 1 protein is responsible for guanine nucleotide exchange. The fact that the two Ran 
GTPase effector molecules appear to be separated by the nuclear membrane has led to some 
confusion. Various mechanisms have been proposed that explain the separate localizations. As 
shuttling of Ran itself through the NPC would be predicted to be an inefficient process, it has been 
proposed that proteins and RNPs could interact with different Ran molecules during translocation. It 
is also possible that the levels of effector protein required for transport do exist but that they are 
below the present detection limits.
The signals recognized by the transport mechanism are at the protein level. Nuclear import of 
proteins has been easier to study experimentally and thus nuclear localization signals (NLS) were
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discovered first. More recently a motif was discovered which signals the rapid export of proteins 
from the nucleus. This nuclear export signal (NES) has been found within the HIV Rev protein 
(Fischer et al. 1995), the transcription factor TFIIIA (Fridell e ta l. 1996) and the protein kinase A 
inhibitor, PKI (Wen et al. 1995). A human factor hnRNP A l was seen to shuttle between the 
nucleus and cytoplasm and be associated with polyadenylated RNA in both compartments. Upon 
closer examination, the protein was seen to contain both an NLS and an NES (Michael et al. 1995).
It is very likely indeed that all RNA molecules are bound by proteins prior to export and that it is the 
protein that signals export and not the RNA. The best example of this is the specific binding of the 
HIV Rev protein to viral transcripts. Binding was shown to lead to transport of the otherwise retained 
RNA out of the nucleus (Cullen and Malim 1991). The "activation domain" of Rev was shown to 
contain an NES (Fischer et al. 1995).
As it has been shown that nuclear import and export of proteins through the NPC are linked - Ran 
GTPase most likely providing the energy for both - it was suspected that the basic mechanisms 
would be similar. NLS-containing proteins are not imported directly but are first bound by a two- 
subunit (a,P) receptor molecule termed "importin'' (Imamoto et al. 1995). The NLS protein-importin 
a,p complex then associates with the outside of the NPC and is transported through, the importin 
subunits being recycled back to the cytoplasm (Gorlich et al. 1995). By analogy, it was proposed 
that an NES receptor molecule would exist which could mediate the interaction with the NPC.
The two-hybrid system was used by three groups, to identify cellular proteins that were able to 
interact with the NES motif of Rev. Two groups found the same human protein termed "Rip" and 
"Rab" (Fritz eta l. 1995; Bogerd eta l. 1995), and the group using a yeast library identified a distantly 
related protein which they termed "Rip Ip " (Stutz eta l. 1995). The Rip protein was then thought to 
be the Rev-NES receptor protein which mediates export of the Rev-RNA RNP. Subsequently, it 
was shown by Bevec etal. (1996) that eukaryotic initiation factor 5A (elF-5A) is able to enhance Rev 
function through binding to the RRE-Rev complex. Two mutant elF-5A proteins which were seen 
also to bind to the RRE-Rev complex, blocked Rev function through preventing the nuclear export 
of the RRE-Rev complex. Expression of the mutant elF-5A proteins resulted in the inhibition of HIV 
replication in human CEM T cells. The authors concluded that elF-5A is a cellular Rev-RRE binding 
factor, which either directly or via subsequent Rip/Rab binding, leads to the export of unspliced and 
incompletely spliced HIV mRNAs.
Xenopus oocyte injection of increasing amounts of a BSA-Rev NES fusion showed that export of 
5 s rRNA and U snRNAs but not mRNA, tRNAs and ribosomes could be competed. This suggests 
that although different classes of RNA are bound by specific proteins, the array of RNP-binding 
receptor proteins could be more limited (Fischer etal. 1995).
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• C/s-acting Positive and Negative RNA Elements
As described earlier, the Rex and Rev proteins appear to be responsible for removing CRS- 
mediated expression blocks from specific viral transcripts. It has been proposed that CRS 
sequences function through binding cellular factors which are not processed by the cell's nuclear 
export system. Some non-retroviral expression systems also take advantage of such a 
posttranscriptional regulation. Influenza virus encodes an unspliced NS1 transcript which is freely 
transported to the cytoplasm where it is subsequently translated. The NS2 protein is expressed 
from the singly spliced form of the NS1 transcript. Initially both proteins are freely expressed. 
Expression of both NS1 and NS2 is then abrogated following the binding of the NS1 protein to a 
sequence within the NS2 mRNA. Both spliced and unspliced transcripts were seen to be trapped in 
the nucleus (Alonso eta l. 1992). The fact that the unspliced NS1 transcript was allowed to leave the 
nucleus suggests that present within the transcript was a c/s-positive element which perhaps via 
binding a cellular factor was able to activate the transcript's nuclear export. However, following 
binding of NS1 protein to its transcript, this hypothetical positive element's effect was no longer 
evident.
The U1 small nuclear RNA (snRNA), important for recognition of splicing signals and initiation of 
splicing when in its RNP form, was shown to encode two c/s-elements which both act to promote 
the transcript's transport to the cytoplasm and subsequent expression (Terns et al. 1993). A 124 
nucleotide stretch at the 5' end of the LHsnRNA and a 3' terminal stem loop structure were shown 
individually to be capable of promoting the nuclear export of U6  snRNAs when inserted into the U6  
coding region. U6  snRNA is normally retained in the nucleus. These experiments were performed 
via injection of specific snRNA into Xenopus oocyte nuclei.
Intron containing genes are usually more strongly expressed than "intronless" genes, presumably 
because the process of splicing stabilizes transcripts and promotes their passage on to the export 
system. One example of an "intron dependent" gene is the p-globin gene. If the (3-globin introns 
are deleted, the resulting cDNA becomes trapped in the nucleus. The herpes simplex virus 
thymidine kinase (HSV-f/c) has been shown to be "intron independent". As it does not require an 
intron for efficient expression it was hypothesized that a c/s-acting positive element must be 
present in the HSV-f/c transcript. This was tested by Liu and Mertz (1995) as they inserted 
fragments of the HSV-f/c gene into an intron-deleted p-globin expression construct. It could be 
shown that a 119 nucleotide region (from 361 to 479) of the tk gene was capable of promoting the 
cytoplasmic accumulation of the intronless (3-globin transcript. The authors concluded that the main 
effect of the 119 nt fragment was upon nucleocytoplasmic transport. The cellular factor found to 
bind to this element was the 6 8 kD hnRNP L protein. The binding was shown to be highly specific 
and to depend upon the element's secondary structure as well as nucleotide sequence. This 
resembles the Rev / RRE and Rex / RxRE mechanisms of HIV and HTLV. In this case the regulatory 
protein is a cellular factor present in almost all cell types whose binding to defined RNA element
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allows the transcript to leave the nucleus and be efficiently expressed. Hepatitis B virus (HBV) has 
also been described to contain a c/s-acting positive element, reported to function similarly to a 
combination of Rev protein and the RRE (Huang and Liang 1993). A region just downstream of the 
env gene (nt 1200 to 1650) was shown to be essential for HBV gene expression and to function at 
the posttranscriptional level to inhibit weak splicing events and promote nuclear export of unspliced 
viral transcripts. When inserted between HIV splice sites, the element could inhibit splicing. 
However, the strong splicing of the (3-globin pre-mRNA could not be inhibited following insertion of 
the element into the IVS2 (3-globin intron. The authors propose that a cellular factor is able to bind 
this element and produce the same effect as HIV Rev. ie. The inhibition of weak splicing, the 
promotion of nucleocytoplasmic transport and subsequent translation.
Finally, Bray et al. (1994) showed that a region of the Mason Pfizer Monkey Virus (MPMV) when 
inserted into a Rev-dependent gag expression plasmid was sufficient to render the expression of 
gag, Rev independent. Although it has not yet been shown, binding of a cellular factor to the 
MPMV sequence could have overcome the transport repression mediated by a cellular CRS 
binding factor. The element identified by Bray et al. was termed a constitutive transport element 
(CTE). The authors suggest that a cellular pathway exists for the transport of intron containing 
transcripts, that are normally prevented from leaving the nucleus.
• Project aims
The initial aim of this project was to construct and test retroviral vectors based on HTLV-I. The strong 
posttranscriptional repression of HTLV-I LTR transcribed mRNAs together with the efficient removal 
of this repression upon the expression of the non-toxic HTLV-I Rex protein made HTLV-I based 
retroviral vectors attractive as a tool for the inducible expression of exogenous genes. As 
construction of retroviral vectors necessitates the removal of all structural and regulatory genes from 
between the LTRs as well as the introduction of "foreign" sequences such as the murine leukaemia 
virus packaging sequence and the gene(s) of interest, it is important to determine whether these 
changes lead to alterations in the pattern of LTR directed expression compared to the wild type 
virus.
As mentioned earlier, the CRS element within the 5' U5 region has been shown to be responsible 
for the posttranscriptional expression block and thus the requirement for the regulatory Rex 
protein. It was important to determine whether presence of this CRS was sufficient for production of 
Rex-dependent expression or whether other sequences were also required.
It is clear that Rex expression is required to release the CRS-mediated repression. However, as Rex 
and its HIV equivalent Rev have both been shown to enhance expression at various 




Ampicillin (Na salt) Serva
Ammonium persulphate (APS) Bio-rad
Bactoagar Gibco
BES buffer Serva








Glycerol 8 6 % Roth
Inorganic salts were supplied by Merck and Roth
Mineral oil Serva
MOPS buffer Merck
Organic solutions were supplied by Merck and Roth




























Restriction enzymes were supplied by Gibco/BRL, AGS NE Biolabs and Boehringer MA.
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RNase A
35g labelled dATP 
T4 DNA ligase 








Chameleon® Site directed mutagenesis kit
Geneclean" kit
Maxi prep kit tip-500











Electroporation cuvette (1,2 & 4 mm) 
Eppendorf tube (0.5ml,1.5ml & Safe-lock) 
Falcon tube (15 & 50ml)
Plastic tube (5 & 12 ml)
"Quadriperm" tissue culture plates 
Roller bottle ( 2L)













Electroporation apparatus Gene Puiser











• Commonly used Buffers
TAB (40 mM Tris-acetate, 1 mM EDTA)
TBE (90 mM Tris-borate, 2 mM EDTA)
TBS ( 25 mM Tris pH 7.4, 137 mM NaCI, 5mM KCI, 0.7 mM CaCl2 .(H2 0 )2 , 0.5 mM MgCl2.(H20)6, 




Centrifuge(15ml & 50ml Falcons)
Centrifuge (125ml Comings)
Centrifuge and rotor (400ml bottles)
Ultra Centrifuge, rotor (5ml tubes)
Speedvac vacuum drier




Sorval RC-4 plus GS-3 rotor 




Jurkat Human T Cell Line 
Simian COS 7 Cell Line 
Hela Cell Line
CD4+ Human T cell 
Simian Kidney cell 
Human Cervical Carcinoma
Gillis and Watson 1980 
Gluzman 1981 
Gey et al. 1952
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O ligonucleotides
No./N  ame: 1 1 /  B CH-F N o./N  ame: 1 2 /  BCH-R
5' 1 AGCjl TGGII AAGII ATC|| T T G ||T A C || CAT|| CGA| S' [ A G qi TTGjl G G qi CAT||CG A|| TGB|| TAG|| AAG|
IT Q G IIC O C IIA  II II II II II 1 iG A T llC T T llC C  11 II II II II 1
De script ion: yygg annealed to  oligo #12 and used t o insert 
a Hind II, Bgl II. Clal multiple clonhg site into 
the existing Hhd III at the 3' end of th e  MLV psi+ 
sequence. The Hhd III site is destroyed at one end.
Description, yygs annealed to olgo #11 and used to  insert 
a Hind II, Bgl II. Cla 1 mult ip le ctonhg site into
the existing Hind 11 at the 3' end of the M .V  psi+ 
sequence. The Hind l i s l e  is destroyed at one end.
No./N  am e; 1 9 /P s i-R N o./N  ame: 2 0 /  Psi oligo
S' 1 ATCII COGIIGACII SAG|| COC|| CCA|| || | S' 1 GA C IITCA II G C q |G C C ||T G T || T  || || |
1 II II II II II II II n 1 II II II II II II II n
Description: Anneals to the M_V psi sequence starting at 
nt. 164 and extending in the antisense orientation.
Was used to sequence "backwards" hto the 5'LTR  
to  check for delet ions of t he U5 CRS sequence.
Description: Anneals to  the l-rrLV-l LTR starting at bp 533 
of prcviral DMA extending in the sense orientation.
Was used for sequencing of LTR U5 regons to check 
for delet ions of the CRB sequence.
No./N  ame: 2 9 /  1 nt2 N o./N  ame: 9 1 /1  ntl -1
5' 1 A C q i A G q iC O C II CAAIl CTGII I Ü I  || A G l|| AAa| S' 1 A G q i G CTIIGCAII GTG|| C A G ||G IC || GAü|| IU l |
1 TTT]! C T C IIT C C Il || || || || I 1 AG /^IG G A ||TG C ||G G G || II II II 1
De script ion: Anneals to the 3' end of the LTR extending in t tie 
antisense orientation. It was used to  re-htroduce the 
correct 3' IR while amplif yhg the 755b p 5' LTR 
(with oiigo #91).
Description: Anneals to pUCIS at the Xho 1 site, was used 
wit h #29 to  PGRthe 755b p 5 'LTR out of plasmid 
No.164.
No./N  am e: 9 2 / 1 n t3 -1 No./N  ame: 9 3 /  1 ntl -2
S' 1 TAGjI TACjl ACAll GTT|| GGG|| GGG|| I GG|| I UU| S' 1 AGGjI G CTllCGAll GAA|| GAG||GCA|| G A l|| GAC|
1 GG II II II II II II II 1 1 A A T jlG A C llC A T llG A G llC C  || || || I
Description: Anneals to the 3' end of the LTR. It was used to 
re-introduce the correct 3'IR wh8e ampiifyhgthe
MLV psi+ (with digo #11).
Description: Anneals to Bluescript at the Xho Is ite . was used 
w ith #29 to  FCRthe755b p 5' LTRout of Bluescript 
based plasmids. Similar to #91. Tm= 65°C.
No /N  am e: 9 4 /  M 1 3
5' I GTAll AAA||CGA|| CGG|rCCÂ|rG [ f
De script ion: (g tvti3 promoter region. Was used
for sequencing inserts in the Bluescript plasmid.
No./N  ame: 9 5 /  PsISOO
Sequence unknown
Description: Anneals to MLVpsi+ sequence approximately 
300 bpfrom  the 5 'end, extending in the sense 
orintation. Was used for sequencing.
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No./N ame: 9 7 / C A T.A .seqS No./N  ame; 9 8 /  C A T .A .seq3
5 ' 1 GCTII CGGII TACII CC || || || || | 5 ' |G T T ||G C A ||T G C ||C T G ||C  || || || |
1 II II II II II II II 1 1 II II II II II II II 1
Description: Anneals to pEL-CAT2 just upstream of tfieCAT  
gene extending in t fie  sense orientation. Was used to 
sequence th e  CAT-poly(A ) insert.
Description: Anneals to pBL-CAT2 just downstream of the 
poly(A) site, extending in t he ant isense orientation.
Was used to sequence t fie CAT-poly(A) insert.
No./N  ame: 9 9 /  T  3 N o./N  ame: 1 0 1 /  CAT-1
5 ' 1 AATII TAAII CCC|| TCA|| CTA|| AAG|| GG || | 5 ' 1 GOCII AAGII G TT||G G A|| GCTII TG G ||C G A ||G A T|
1 II II II II II II II 1 |T T T ||C A G ||G  II II II II II 1
Description: Anneals to T3 promoter sequence. Was used for 
sequencing of inserts in Bluescript and together with 
t fie 1^3 oligo (#94) or T7 oligo (# 149) for quick 
PCRscreening of miniprep. bacterial colonies.
De script ion: Anneals to pB_-CAT2 just upstream of the CAT 
gene, extending in the sense orienta tio n, introducing a 
Hind II site. Was used to  FCR amplify th e  CAT gene 
without the poly (A). Used with oligo #102.
N o ./N  a m e: 1 0 2 /  GAT-2 N o ./N  am e: 1 0 5 /  R RE2
5' 1 GAA||GAT|| CTA|| CCA|| GGG|| G T T||TA A ||G G G | 5' 1 GGTjl C TA ||GAG|| TT T || A TT||G A G || GGA|| TAT|
I C A C I I C  II II II II II II 1 1 â c q i  II II i i ~  II II  i n  1
Description: Anneals to pEL-CAT2 just upstream of the 
poly(A)site, extending in the antisense orientation, 
intro du chg a Bgl 1 site. Was used to FCRamplif y the 
CAT gene without tfie poly(A). Used withoBgo #101.
Description: Anneals to the HTLV-I LTR, to cover the 
poly(A) signal, extending in tfie antisense orientât km. 
Tfie oligo int roduces an Xba 1 site at tfie 3' end of tfie 
U3 regon. I was used together with ofigo #93 to 
FCR amplify the U3 region. Tm= 5 0 .5°C.
No./N  ame: 1 0 6 /  R RE3 N o./N  ame: 1 0 7 /R R E 4
5' 1 GCTII GTAll GAT|| GAA|| G TG ||TA C || GTC|| TTT | 5 ' 1 GCTII COGII AGCII TGA|| C TG ||T G T || ACT|| AAA|
I g h t i i t c  II II II II II II 1 IT T T I I  C TC IIT C C Il || || || || |
De script km: Anneals to the HTLV-I LTR, to cover the 
pcly(A) site, extending in tfie sense orientâtion.The 
oPgo introduces an Xba 1 site at t fie 5' end of tfie 
U5 region. 1 was used together with oligo #107 to  
FCR amplify the U5 region. Tm= 53°C.
Description: Anneals to the HTLV-I LTR at tfie 3'end of tfie 
U5 region, extending in the antisense orientation.
The oligo introduces a Sac Isite at the 3' end of the 
US region. 1 was used togetfier withoSgo #106 to  
FCR amplify tfie U5 regkm .Tm = 5 2 .7°C
No./N  ame: 1 0 8 / Kpnl No./N  ame: 1 0 9 / H in d  III
S' 1 GTAll TAG||GGC|| GAA|| TTG||GGT|| GCq| GGq S' 1 GGqi TOG||TCC|| GGq| ATA||AGC|| TTA|| GGG|
1 CCCII C C C IIC TC II GAGII || || || | 1 CTGII CCCII AGGIt G A C ||C  || || || |
Description: Anneals to tfie Bue script plasmid covering and 
destroying the Kpn 1 site, extendng ki the sense 
oriental km to include tfie Hhd III sit e. Was used as t fie 
"seiection" primer during SDf^ with oigo# 109. Tfie 
oligo is non-pfiosphorylated.
Description: Anneals where the 5 'LTRborders tfie IVLV psk- 
sequence, extending in t fie sense direct km to  insert a 
Hind II site just downstream of the 5'LTR. Used in an 
SDIVIprotocol with oligo#108. TheoSgo is non- 
phosphorylated.
No./N  ame: 11 3 /  U 3 -M un N o./N  ame: 11 4 /  U 5 -M un
5' 1 GOCII GGA||ATT|| GGq| ATC||CAG|| CAG|| GAG| 5' 1 CGGII GAAjjTTGjj AGAjj t Gt ||AGG|| ACqi GTG|
IT C T II A T A IIA A A IIG C q i || || || | 1 A G q i GTCIIAGGII CAA|| AGQI G || || |
Description: Anneals to tfie ffTLV-l LTRat the 5 'end of the 
R region, extending ki thesense orientation to exclude 
tfie poly (A) signal but introduce Mun 1 and BamHI 
sites. Used togetfier wit h oSgo #114.
[Description: Anneals to the HTLV-I LTRat the3 'end cf the 
R region, extending ki the antisense orientation to  
exclude the poly(A) site but introduce Muni and Bgl II 
sites. Used togetfier with oligo #113 to FCR tfie FkRE 
as a l^ n  1 fragment.
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No./N  ame: 1 1 5 /  5 'CAT-rev No./N  ame: 1 1 6 / ORI-Xfiol
5 ' 1 GCTII GCTII GftAII AAT|| CTO|| GCC|| || |
1 II II II II II II II 1
5' 1 CCGII CTGII GAGII CAT|| C TC ||A T G || GCT|| GAC| 
1 TAAII T II II II II II II 1
Descript ion:Anneals just upstream cf the CAT gene, 
extending in ttie antisense orientation. This oligo is 
complementary to #101 which was used to  PCRttie CAT 
gene from pBL-CAT2. Was used to  sequence f4LV Fbi 
fragments once inserted into tfie SDfvted Hind III site.
De script ion: Anneals to t fie 5' end of the SV40 origin of 
replication, extending in the sense oriental ion to 
int roduce an Xfx) Isite. Used togetfier with oigo #117. 
Tm= 50. 5°C.
No./N  ame: 11 7 / ORkSal 1 No./N  ame: 11 9 /  pBS.reverse
5' 1 A C q i CGT||CGA|| CAA|| G C q |T O C || TCA|| C IA | 5 ' 1 GGAII A A Q IA G C II TA TII G A G||CAT|| G || |
IC T T I IC  II II II II II II 1 1 II II II II II II II 1
Description: Anneals to the 3 'end of the SV40 origin of 
replication, extending in tfie antisense oriental ion to  
int roduce a Sal Isite. Used together with olgo #116.
Description: /Vi ne als to the Bue script plasmid covering the 
jFgalactosidase ATGsite at bp 816. Used to  sequence 
inserts in th e  Bluescript plasmid.
N o./N  ame: 1 4 6 /  R -SD N o./N  ame: 1 4 7 / R-SD.2
5 ' 1 CCC|| A A q iC T T II GGT|| TG A||G TG || G C q |T fC | 5 ' 1 GCCIl A A q i C T T Il G O q| TTG|| A GT|| C G q | GTT |
IT G  II II II II II II II 1 IC T G IIC C  11 II II II II II 1
De script ion: /Vine als to t he HTLV-1 LTR just upst ream of t he 
Splice donor sit e. Used with oBgo #115 to d etect  
spfcing events in constructs containing th e  Psi312 
fragm ent.
Description: Same as oligo #146 but with an extra 3 "C  
nudeotides to  increase the Tm (61 °C).
N o./N  ame: 1 4 8 /  -
5' I GCTil TOCliTTAll GCT|| CCT|| SAA|rÂÂT|rcTCl
fscêir
Description: Same as oligo #115 but witfi an extra 9
nucleotides at 5' end t o increase the Tm (64°C).
No./N  ame; 1 4 9 /  T  7
5' rGTÂjrÂTÂirCGAII CTC|[ÂCT]rÂTÂ][~G^[C'
De script ion:An ne als to T7 promoter sequence. Was used tor 
sequencing of inserts in Bue script and together with 
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pRK7-tax: Chlichlia et al. 1 995
pRK7-rex: Rehberger et a I. submitte d
pBL-CAT2: Lukow and Schütz 1987
HTLV-tat 1: Nerenberg et al. 1 987






Bam HI 3002 Bgl II 2152
BamHI-HInd III fragm ent 
derived from  pH TLV -ta tl
Methods 20
• Growth of Bacterial Cultures
Liquid bacterial cultures were grown at 37°C, with 200-250 rpm shaking. LB medium was 
prepared according to Maniatis et al. Ampicillin was used at a concentration of 0.1 mg/ml 
(lOOmg/ml stocks were stored at -20°C). Depending on the size of culture, various culture 
vessels were used:
Purpose____________________________________ Vessel_______________ Volume
Post-electroporation incubation 12 ml plastic tube 1 ml
Mini prep 12 ml plastic tube 2 ml
Midi prep 250 ml Conical flask 50 ml
Competent cells 2 L Conical flask 400 ml
Maxi prep 2 L Conical flask 100-500 ml
Maxi prep culture volumes varied depending on the plasmid type being grown. Smaller 
volumes were used when growing up plasmids with a high copy number.
To plate out transformed bacteria, LBamp agar plates were prepared. A 1.2% solution of 
agar in 1x LB medium was autoclaved (120°C, 20 minutes) and allowed to cool to 50°C. 
Ampicillin was added to a final concentration of 0.1 mg/ml. 20 ml of LBamp agar was then 
poured into each sterile 10 cm petri dish. Plates were stored for up to 2 months at 4°C.
• Preparation of E lectro-com petent Bacteria
Competent cells (E. Coli strain HB101) were prepared from a 400 ml LB culture which was 
grown to an optical density (O.D) at 600 nm, of 0.3 - 0.5 units. Bacteria were maintained in 
an exponential growth phase, having first been plated out the evening before on an LB 
agar plate. Early the next morning, 2 ml of LB medium was innoculated with a single 
colony and grown for approximately 2-3 hours, whereon 500 pi was used to innoculate a 
400 ml LB culture. A further 3-4 hour incubation was then requiredbefore the optimal 
OÜ600 was reached.
All solutions, pipettes, vessels and rotors were pre-chilled to 4°C. Centrifugation steps 
were all carried out at 4°C. The culture was first chilled on ice for 10 mins before 
centrifugation at 4000 rpm for 15 mins in a Sorvall GS-3 rotor. The supernatant was 
removed and the cells resuspended in 10 ml of Im M  HEPES (pH 7) solution. The volume 
was then increased to 300 ml with HEPES and re-centrifuged at 5000 rpm in the same 
rotor. This washing step was repeated once. Following this third centrifugation step, the 
supernatant was removed and the cells resuspended in 30 ml of sterile 10% glycerol and 
transferred to a 50 ml Falcon tube. This was then centrifuged at 3000 rpm for 15 mins in a
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Heraeus "Variofuge" (max. of 6000 rpm). The supernatant was removed and the cells 
resuspended in 800 pi of 10% glycerol. The cells were aliquoted, immediately snap- 
frozen in liquid nitrogen and transferred to -70°C, where they were kept for up to 2 
months. The transformation efficiency of each fresh batch was tested by electroporating 
0.1 ng of pUC 18 plasmid DMA. An efficiency of 1 million colonies per pg DMA was 
obtainable.
This HEPES washing procedure removes the salt (from the LB medium) which, if present 
during the electroporation procedure, would lead to a reduced electroporation efficiency.
• Electroporation of Competent Cells with Plasmid DNA
Electroporation was carried out using 40 pi of electro-competent cells and 1-3 pi of 
plasmid DNA-containing solution. If the DNA was derived from a previous plasmid prep 
then 10-100 ng was used. If, however, the DNA was derived from a ligation reaction, then
1-2 pi were used. The ligation mix contains salt, thus the volume of mix should be kept 
below 2 pi. Alternatively, the ligation mix can be phenol-chloroform extracted, ethanol 
precipitated and resuspended in a small volume of distilled water, before electroporation. 
Sterile electroporation cuvettes with a 0.1 or 0.2 cm electrode gap were pre-chilled on ice. 
The competent cells and DNA were then mixed by gentle pipetting in an eppendorf tube 
and transferred to the cuvette. Using the Bio-rad Gene Puiser device, the mix was pulsed 
at 2.5kV with a capacitance of 960 pF yielding an optimal time constant of 4.4 - 4.6 mS. 
This is the time taken for the pulse to cross the electrode gap. High salt concentrations 
promote a quicker conductance which leads to a lower transduction efficiency. 
Immediately following pulsing, 1ml of sterile ice cold SOC medium (bactotryptone 20g/L, 
yeast extract 5g/L, NaCI 0.1 M, KOI 2.5 mM, MgCI 10 mM, MgS0 4  5 mM) was added, the 
cells gently mixed and transferred to a 12 ml plastic tube for 60 minutes at 37°C with 
shaking. After this time, 100 pi was plated out on LBamp agar plates, the remainder was 
centrifuged (4000 rpm in an Eppendorf mini centrifuge) for 2 minutes. 800 pi of the 
supernatant was removed, the cells being resuspended in the remaining 100 pi. These 
were then also plated out on LBamp agar plates. Both plates were inverted and incubated 
at 37°C overnight (16 hours) to allow ampicillin resistant colonies to grow.
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• Plating out bacteria on LB (LB-amp) Plates
Bacteria from frozen stocks were plated out via "streaking". Here an innoculating stick was 
used to transfer the concentrated bacteria to the plate as 3 parallel lines at a tangent to the 
plates circumference. A fresh innoculating stick was then taken to make new streaks that 
started by crossing the old streaks. This was continued until the plate had been 
completely rotated to give 5 to 6 sets of tangents ensuring that at some point in the 
dilution procedure, single colonies would appear. The plates were incubated for 16 hours 
at 37°C to allow colonies to grow.
Bacteria from electroporations were centrifuged gently at 4000 rpm (eppendorf 
centrifuge) in 1.5 ml eppendorf tubes. The supernatant was carefully removed so as to 
leave approx. 100 pi of supernatant behind (SOC medium). The bacteria were then 
carefully resuspended in this medium via pipetting before being transferred to the surface 
of the LB-amp plate. This 100 pi was then spread across the surface of the plate using a 
sterile innoculating loop. Plates were allowed to air-dry before being incubated for 16 
hours at 37°C.
• Small Scale ("TELT") Plasmid DNA Preparation
Following electroporation and overnight selection on LBamp plates colonies were picked 
and used to innoculate both a fresh LBamp plate and a 2 ml volume of LBamp medium in a 
12 ml plastic tube. The plate was incubated at 37°C overnight and the 12 ml tube at 37°C 
with shaking for a minimum of 5 hours. A quick (same day) mini prep procedure was used 
which yielded a small but sufficient amount of plasmid DNA to allow 5-10 restriction 
enzyme digestions or 2-3 sequencing reactions. The advantage of this method being 
that batches of 24 preps can be easily prepared in under 2 hours on the day of 
innoculation allowing subsequent restriction digest analysis and innoculation of 400 ml 
LB for a large scale plasmid prep on the same day, effectively saving one working day. 
First, the mini cultures were spun down in eppendorf tubes (8000 rpm for 1 min) and the 
supernatants removed via aspiration. 100 pi of TELT buffer (2.5 M LiCI, 50 mM Tris pH 8, 4 
% (v/v) Triton X-100, 62.5 mM Na2 EDTA) was added to each tube using an eppendorf 
multi-pipette. The tubes were transferred to an eppendorf shaker and shaken for 30 
seconds to resuspend the bacteria. In this buffer the bacteria are also lysed. Immediately, 
100 pi of phenol-chloroform (1:1) was added and the tubes shaken once more - this time 
for 1 minute to ensure good mixing of the organic phase with the lysate proteins. This was 
then centrifuged at 13000 rpm for 5 minutes at RT to separate the phases. The upper 
phase was transferred to a fresh eppendorf tube and precipitated with 300 pi of 100% 
ethanol. This was then immediately centrifuged at 13000 rpm for 3 mins. The supernatant
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was removed and the pellet washed with 500 pi of 75% ethenol to remove the large 
amounts of salt (LiCI) present. A second wash step was optional. Following the final 
centrifugation, the supernatant was removed, the pellet allowed to dry briefly in a 
"Speedvac" drier before being resuspended in 30-50 pi of TE (pH7.4). For restriction 
enzyme digestions 5-10 pi was used with 1 pi of DNase-free RNase in addition to the 
suitable restriction enzyme.
• Restriction Enzyme (RE) Digestions
Most RE manufacturers supply enzymes with an activity of 10 or 20 units/pl in glycerol (for 
stability). One unit is required to cleave one pg DNA in one hour at the optimum (usually 
but not always 37°C) temperature. Digestions were carried out with an excess of 3-5 fold. 
This excess activity can either be achieved by extending the incubation period to 3 or 5 
hours instread of one or by using 3-5 times more enzyme in a one hour digestion. In 
practice, shorter digestions were preferred for mini prep DNA. Glycerol concentrations 
over 10% seriously decrease the activity of restriction enzymes. For this reason, the 
volume of enzyme was kept below 10 % of the total reaction volume. (NB. The RNase 
used in digestions of mini prep DNA is also stored in glycerol.)
• Large Scale (Midi) Plasmid DNA Preparation
When a large amount of DNA was required, which did not need to be pure enough for the 
transfection of eukaryotic cells, a "midi prep" was carried out. 50ml of LB was innoculated 
with a single colony from an LBamp plate. This was grown up overnight at 37°C with 
shaking. The following day, the culture was transferred to a 50ml Falcon tube and 
centrifuged for 10 minutes at 4000 rpm in a Heraeus centrifuge. The supernatant was 
removed and the bacteria resuspended in 9 ml of chilled GTE buffer (50 mM glucose, 25 
mM Tris pH 7.6, 10 mM EDTA, 400 pg/ml RNase A). Next, 9 ml of lysis buffer (200mM 
NaOH, 1% SDS) was added, mixed carefully and kept at RT for 10 minutes. 9 ml of 
Neutralizing buffer (5M Acetic acid, 3M KAc) was then added and again carefully mixed. 
This was incubated on ice for 20 minutes and then centrifuged for 30 minutes at 17000 
rpm in an SS34 rotor in a Sorvall refrigerated centrifuge at 4°C. The supernatant was 
removed and precipitated with 0.7 volumes of Isopropanol on ice for 30 minutes. This was 
then centrifuged at 5000 rpm for 30 minutes at 4°C in 50 ml Falcon tubes to pellet the 
nucleic acids. The supernatant was removed and the inside wall of the tube dried with a 
sterile paper tissue. The pellet was resuspended in 2 ml of TE buffer (10 mM Tris pH 7.4, 
1 mM EDTA). 2 ml of 5M LiCI was then added and mixed well. Following a 30 minute
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incubation on ice, this was centrifuged for 30 minutes at 5000 rpm at 4°C to pellet the 
precipitated RNA. The supernatant (4 ml) was then transferred to a fresh 15 ml Falcon 
tube and precipitated with 2 volumes of 100% ethanol on ice for 30 minutes. This was 
centrifuged for 30 minutes at 4500 rpm (Heraeus) at 4°C to pellet the DNA. The 
supernatant was discarded and the DNA pellet resuspended in 500 pi TE. This was then 
sequentially extracted with one volume of phenolichloroform (1:1) and then with one 
volume of chloroform:lsoamylalcohol (24:1). The final upper phase was then precipitated 
with 2 volumes of 100% ethanol at -20°C. This was then centrifuged at 4500 rpm at 4°C. 
The supernatant was removed, the pellet washed twice with 2 ml of 75% ethanol and re­
centrifuged. The supernatant was removed, the pellet dried briefly in a "Speedvac" 
vacuum drier and resuspended in 500 pi of TE (pH 7.4). The concentration of DNA was 
then determined spectrophotometrically at 260 nm. An OD2 6 O of 1 0 is equivilent to a 
concentration of 50 pg double stranded DNA / ml. Total yields of 1-2 mg were obtainable. 
Midi prep solutions were almost completely free of RNA, containing only a low level of 
protein but because of the presence of highly toxic bacterial lipopolysaccharides (LPS), 
they were not suitable for eukaryotic transfections. They were, however, ideal as 
substrates for in-vitro sub-cloning procedures.
• Large Scale (Maxi) Plasmid Preparation
To prepare larger amounts of plasmid DNA for use in eukaryotic transfections, two 
protocols were available. The traditional method, which can yield large amounts (1-2 mg) 
of plasmid DNA is a two-day process. The first day is similar to the method described 
above. At the end of the first day, the DNA is centrifuged in a CsCI gradient to separate 
the DNA from RNA and protein. The DNA bands can be removed from the polyalomer 
tubes using a syringe and needle and then further processed to remove the ethidium 
bromide (used to visualize the DNA bands) and high concentration of CsCI salt. To obtain 
ultra pure plasmid DNA a second CsCI centrifugation should be performed.
An alternative to this method, which also yields pyrogen-free plasmid DNA, albeit in lower 
amounts (500-1000 pg), is the affinity chromatograpy-based method introduced by 
Qiagen Ltd. This process takes 2-3 hours and produces ultra clean DNA which was used 
to gain very reproducible results in eukaryotic transfection protocols. The level of purity is 
claimed to be equivalent to two rounds of CsCI purification and is sufficient for use in in- 
vivo human gene therapy protocols.
For the Qiagen method, it is important not to use excessive amounts of bacteria. As the 
columns used only bind 500 or lOOOpg plasmid DNA, it is recommended to use 
significantly smaller culture volumes when growing up plasmids with a high copy number.
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With such plasmids, 500 pg is easily obtained from a 50 ml culture. Use of 400-500ml is 
only recommended for low copy number plasmids such as pBR322.
Bacteria were harvested by centrifugation and resuspended in 10 ml of chilled buffer PI 
(50 mM Tris-HCI pH 8.0,10 mM EDTA, 100 pg/ml RNase A). 10 ml buffer P2 (0.2M NaOH, 
1% SDS) was then added to lyse the bacteria for 5 mins at RT. 10 ml of chilled 
neutralization buffer P3 (3M Potassium Acetate, pH 5.5) was then added, mixed gently 
and centrifuged at 17000 rpm for 40 mins at 4°C in an SS34 rotor in a Sorvall centrifuge. A 
"TIP-500" column was then equilibrated with 10 ml of equilibration buffer (750 mM NaCI, 
50 mM MOPS, 15% ethanol pH 7.0, 15% Triton X-100). The supernatant was applied to 
the column, the DNA binding to the DEAE-based substrate. Three wash steps (each 
10ml of 1M NaCI, 50 mM MOPS, 15% ethanol pH 7.0) were carried out to remove 
unbound protein, RNA etc. The remaining DNA was then eluted from the column with 15 
ml of elution buffer (1.25 M NaCI, 50 mM Tris-HCI, 15% ethanol pH 8.5) and precipitated 
with 0.7 volumes of isopropanol. This was centrifuged at 5000 for 30 mins at 4°C 
(Heraeus) to pellet the DNA. The supernatant was then removed and the pellet washed 
twice with 75% ethanol. The pellet was finally dried briefly and resuspended in 300-500 pi 
TE (10 mM Tris-HCI, 1 mM EDTA pH 8). This solution was then assayed at OD2 6 O for both
DNA concentration and purity.
• Freezing Bacterial Stocks
Plasmid-containing bacteria were harvested prior to maxi plasmid DNA preps, pelleted at 
3000 rpm for 5 minutes at room temperature and resuspended in 200 pi of LB medium. 
600 pi of 86% glycerol was then added and mixed. These aliquots were then stored at -70 
°C for future maxi prep innoculations.
• Gel Electrophoresis of Plasmid DNA
Plasmid DNA fragments were separated via gel electrophoresis through either 0.8% or 
1.2% agarose gels. Agarose was heated in IxTAE buffer in a microwave oven until no 
undisolved agarose remained. Once the agarose had cooled to approximately 50°C, 
ethidium bromide was added to a final concentration of 0.5 pg /m l. This solution was then 
kept at 50°C (for up to a week) until needed. Agarose gel loading buffer (0.2% SDS, 10 
mM EDTA, bromophenol blue 0.004%, glycerol 10% pH 7.5 final concentration) was 
added to each sample to facilitate loading and also to allow the visualization of the running 
front. Gels were electrophoresed at 100V /90 mA in a Pharmacia mini gel apparatus.
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• Polyacrylam ide Gel Electrophoresis (PAGE)
Polyacrylamide gels were used to run the products of DNA sequencing reactions. An 8% 
gel was made by taking 8 ml of a 40% acrylamide / 2% BIS stock solution. Ion-exchange 
beads were kept in the stock solution to help prevent polymerization. To this was added 
19.4 g ultrapure urea, ddH20 up to 40 ml and some Serdolit ion-exchange beads. This 
was heated at 50°C for 15 mins with an electronic stirring bead and then filtered through 
Whatman filter paper onto 8 ml of 5 times TBE buffer. While this solution was on ice, 160 
pi of 10% ammonium persulphate (APS) and 16 pi of TEMED was added. This was mixed 
and then de-gased by quickly drawing the solution into a 50 ml syringe through a 
hyperdermic needle. The solution was then injected slowly between the two glass gel 
plates and allowed to polymerize at room temperature for approximately 60 minutes.
• Determination of DNA and RNA Concentrations
5 pi of the sample nucleic acid solution was brought to 700 pi with distilled water. The 
photometric absorbances at 260 and 280 nm were then measured relative to a distilled 
water blank. The concentration (pg/ml) of dsDNA is calculated by multiplying the A2 6 O by 
the dilution factor and by the standard absorbtion coefficient for DNA (50). For RNA and 
single-stranded (ss) DNA the absorbtion coefficient is 37. 
i.e. A 26O of 1.0 results from a dsDNA solution of concentration 50 pg/ml
A 26O of 1.0 results from a ssDNA /RNA solution of concentration 37 pg/ml 
A measure of the purity of the DNA or RNA can be made by dividing the A2 6O by A280. 
Values of 1.7 -1 .8  for DNA and 2.0 - 2.1 for RNA indicate good purities. Lower ratios (1.5- 
1.6) indicate the presence of protein.
DNA fragment concentrations were estimated by running various dilutions of the fragment 
against a known amount of digested lambda marker DNA and comparing band intensities.
• Purification of DNA Fragments
Following digestion of plasmid DNA by restriction enzymes (RE), the DNA fragments 
could be isolated and purified. The method of purification depended upon the size of the 
fragment and whether RE digestion led to one or more fragments as well as the difference 
in size between the fragments.
Direct Genecleaning:
Where a plasmid had been digested in preparation for insertion of another DNA fragment 
(insert), either by linearization or by cutting twice to release a small piece of the plasmid 
(multiple cloning site), it was not necessary to run the fragment(s) on an agarose gel. The
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DNA were purified directly from the RE digestion mix using the "Geneclean" kit. 3 
volumes of sodium iodide solution was added to the digestion mix. 5 pi of "glassmilk" 
(silica substrate) was added to this mixture and incubated at room temperature for 5 
minutes. Glassmilk binds DNA fragments larger than 500 bp with efficiencies of up to 
90%. Small fragments effectively do not bind.The glassmilk was pelleted by centrifugation 
and washed 3 times with 600 pi of -20°C "New Wash" solution - 70% ethanol with high salt 
concentration. This removed the sodium iodide salt but ensured that the DNA remained 
bound to the glassmilk. The DNA was eluted by resuspending the glassmilk in low salt 
solution (distilled water or TE buffer pH 7.4) and incubating at 50°C for 10 minutes. A small 
portion of the eluate was then run on an agarose mini gel to check the DNA yield.
Gel and Genecleaning;
Fragments larger than 500bp were purified by first running the mixture on an agarose gel 
and cutting out the band of interest. It is important to excise the band in the smallest 
amount of agarose possible. This was transferred to an eppendorf tube and weighed. 
Where the agarose weighed more than 300 mg then it was divided into two fractions and 
processed separately. 3 volumes of sodium iodide was added to the agarose and heated 
at 50°C until the gel just melted. Glassmilk was then added and further processed as 
described above.
Gel and Electrolution:
Small DNA fragments (20-2000 bp) were removed from the gel by cutting a slit in the gel, 
just in front of the band, inserting a small piece of DEAE cellulose paper and running the 
gel further so that the band ran "on to" the paper. The paper was then washed well in 
distilled water to remove any remaining agarose gel, placed at the bottom of an eppendorf 
tube and just covered with a solution of 1M NaCI and heated to 65°C for 30 mins to elute 
the bound DNA. DNA fragments larger than 2.5 kb do not elute very well from the paper 
as they are too tightly bound. The eluate was extracted with one volum e of 
phenokchloroform (1:1) and precipitated with 0.2 volumes of 10M ammonium acetate and 
2.5 volumes of 100% ethanol. This was then centrifuged at 13000 rpm for 15 minutes to 
pellet the DNA which was then washed twice with 500 pi of 70% ethanol, briefly dried 
under vacuum in a Speedvac and resuspended in either distilled water or TE buffer, pH 
7.4.
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• "Blunting" of Restriction endonuclease digested DNA ends
Digestion of DNA with a restriction endonuclease typically results in production of either a 
5' or 3' overhang. This "sticky" end can be "blunted" in a reaction catalysed by T4 DNA 
polymerase. Normally, the sticky end is a 5' overhang. In this case the polymerase will 
extend the 3' end until flush - or blunt. In the case of a 3' overhang, the enzyme will 
degrade it back until blunt. This is possible because the enzyme has both a 5'-> 3' 
polymerase activity and 5'<->3‘ single strand exonuclease activities. In the presence of 
dNTPs, the enzyme's polymerase function dominates.
3-4 pg of digested DNA in a total volume of 39 pi was added to an eppendorf tube. To this 
was added 5pl of dNTPs (6 mM each), 5 pi of 10x Klenow buffer and 1 pi of T4 DNA 
polymerase (5 units). This was incubated at 15°C for 20 minutes after which the reation 
was stopped upon addition of 1pl of 0.5M EDTA. 0.1 volumes of 3M sodium acetate (pH 
4.8) was added and the mixture extracted first with one volume of phenohchloroform (1:1) 
and then with one volume of chloroform: isoamylalcohol (24:1). The final aqueous phase 
was then precipitated by addition of 0.7 volumes isopropanol and incubation for 10 
minutes at room temperature. Following centrifugation, the pellet was washed in 100 pi of 
70% ethanol, breifly dried under vacuum and resuspended in 10-20 pi of TE (pH 7.4). 1 pi 
was then run on an agarose gel to estimate the new DNA concentration.
• Dephosphorylation of Plasmid DNA ends
When ligating a DNA fragment (insert) into a single site of a plasmid (vector), one can 
either use a 5:1 insert to vector ratio and be prepared to do 24 mini preps to determine 
which bacterial colonies contain the desired vector-insert combination or modify the ends 
of the vector DNA so that they are no longer able to re-circularize (and give rise to 
ampicillin resistant colonies). The ends were modified by a phoshatase enzyme (purified 
from calf intestine) known as CIP. This removes the Phosphate group from each end of 
the vector DNA making re-circularization impossible. The insert DNA, however, still has 
both phoshate and hydroxyl groups at each of its ends and is thus able to ligate with the 
vector DNA. In this case a 1:1 vector to insert ratio is sufficient and should result in all 
ampicillin resistant colonies containing the vector and one or more inserts in either of the 
possible orientations. It should be noted that phosphatasing leads to a marked reduction 
in ligation efficiency.
2-3 pg of vector DNA in a total volume of 17 pi was added to an eppendorf tube. To this 
were added 2 pi of lOx CIP buffer and 1 pi of CIP enzyme (2-3 units). This was incubated 
for 30 minutes at 37°C and the reaction stopped upon addition of 2 pi of EGTA (100 mM
Methods 29
stock concentration) and incubation for 15 minutes at 75°C, to inactivate the CIP. 1 pi of 
glycogen carrier and 0.2 volumes of 10M ammonium acetate were added. The mixture 
was then extracted, first with 1 volume of phenohchloroform (1:1) and then with one 
volume of chloroform:isoamylalcohol (24:1). The final aqueous phase was precipitated 
with 2.5 volumes of 100% ethanol, washed twice with 70% ethanol, dried briefly under 
vacuum and resuspended in 10 pi of TE (pH 7.4). 1 pi was then run on an agarose gel to 
estimate the new DNA concentration.
• Kinasing of DNA ends
DNA fragments destined for ligation into a plasmid are usually digested with one or two 
restriction enzymes to yield either sticky or blunt ends. These ends have terminal 
phosphate groups, essential for the subsequent ligation reaction. In some cases the 
inserts are generated via the PCR, and if the PCR polymerase used has a proof-reading 
function (such as Vent or pfu) then the PCR product ends will be blunt. If restriction 
enzyme cleavage sites were not included at the 5' ends of both oligos, then the fragment 
must be ligated with one or two blunt ends. A PCR generated blunt end lacks the terminal 
phosphate group and can therefore be modified prior to ligation.
100 pmoles of DNA fragment in 12pl dH20 was added to an eppendorf tube. To this was 
added 2 pi of lOx buffer (0.2 M Tris pH 7.6, 0.1 M MgCl2 , 10 mM DTT), 2 pi of 160 pM 
ATP and Ip l of polynucleotide kinase. This was incubated for 30 minutes at 37°C, and the 
reaction stopped upon addition of 2 pi of 0.5 M EDTA.
• Ligation of DNA Fragments
The exact protocol used for a ligation reaction depended upon the relative lengths of the 
fragments, the nature of the ends (sticky, RE blunt, T4 pol blunt, PCR blunt and/or 
phosphatased) and the abundance of each fragment. The optimal molecular ratio of 
vector to insert could only be estimated once small portions of each fragment had been 
run next to one another on an agarose mini gel.
Reaction One: Vector and insert each have two different sticky ends (eg. Bam HI &
EcoRI). In this case, a 1:3 molecular ratio was sufficient in a standard reaction at 16°C 
overnight. The standard reaction consisted of 200 - 400 ng DNA, T4 DNA ligase buffer 
(50 mM Tris-HCI pH 7.6, 10 mM MgCI, 10 mM DTT, 50 pg/ml BSA), 5 mM ATP, dH20 up to 
9 pi and 1 pi T4 DNA ligase. Before addition of the ligase, the mix was incabated at 40- 
50°C for 5 minutes and then placed directly on ice for 5 minutes. This melted any 
cohesive ends which may have formed between vector and vector as well as between 
insert and insert and thus increased the efficiency of correct (vector-insert) ligations. For
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each ligation reaction two control reactions were included - one lacking insert DNA and 
the other lacking the ligase enzyme. When the ligation reaction was complete, 2.5 pi of 
each of the three reactions was run on an agarose mini gel. From this it could be 
determined whether the vector and insert fragments had ligated. The reaction including 
vector, insert and ligase produced many bands, identification of the correct vector-insert 
band being difficult. The ligase minus lane shows the positions and quantities of both the 
vector and insert bands "before ligation". The insert minus lane shows the position of the 
vector-vector multimers which are also produced if the vector DNA is not CIPed. By 
subtracting the control bands from those of the target reaction, the correct vector-insert 
band can be identified more easily.
Reaction Two: Vector and Insert have one blunt and one sticky end (eg. EcoRV &
EcoRI). This reaction is the same as that described above. The sticky ends ligate more 
readily than the blunt ones but it is still a directed cloning.
Reaction Three: Vector and insert ends are all the same or compatible (eg. Bam HI or 
Bam HI & Bgl II). In this case vector and insert ends can ligate with themselves as well as 
with one another. Furthermore, the insert is able to ligate in in both orientations and with 
multiple copies. The orientation of the insert can be determined by screening the 
colonies following electroporation. There are two ways of increasing the chances of 
correct, vector-insert ligates. The vector molecules can be treated to remove their terminal 
phosphate groups. This prevents vector-vector ligations but also leads to a reduced 
ligation efficiency. The efficiency of dephosphorylation can be analysed by looking at the 
insert minus control lane of the agarose mini gel after ligation. Alternatively, the vector : 
insert can be increased to 1:6, or with very small fragments up to 1 :10.
Reaction Four: Vector and insert both have blunt ends. In this case, intra-molecular
ligation is always kinetically favoured. Three measures can be taken to optimize the 
chances of inter-molecular ligations. Firstly, the reaction temperature can be dropped to 
12°C and allowed to proceed for more than 24 hours. Secondly, a higher insert to vector 
ration can be used (6:1 to 10:1). Thirdly, the effective concentration of the DNA ends can 
be artifically increased by adding polyethylene glycol (PEG 6000) to the reaction mixture 
to a final concentration of 5 %.
• Sequencing of Plasmid DNA
DNA was sequenced using the T7 sequencing kit from Pharmacia.
1-2 pg of DNA was denatured with NaOH (final concentration 200 mM). The addition of 
sodium acetate neutralized the pH and the mixture was then precipitated with 2 volumes 
of 100% ethanol. The pellet was resuspended in 10 pi TE and kept on ice. The primer
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was annealed to the template at a molecular ratio of 5:1 using the kit's annealing buffer 
and incubation first at 37°C for 30 minutes and then at room temperature for 30 minutes. 
The stock T7  polymerase was diluted 1:4 using the kit's enzyme dilution buffer and kept 
on ice. Next the enzyme pre-mix was pipetted together in an eppendorf tube on ice. This 
consisted of diluted enzyme, 35s labelled dATP and the kit's labelling mix. After a 5 
minute incubation at room temperature, a portion of the mix was added to each of four 
wells of a 96 well plate. The wells contained a nucleotide mixture of three dNTPs and one 
ddNTP, each well containing a different ddNTP as the chain terminator. The short mix (up 
to 400 nt extension) was always used as this was found to give the most accurate and 
reproducible results. The reaction was incubated at 37°C for 5 minutes and then stopped 
upon addition of 5  pi of the kit's stop buffer, which later acted as loading buffer.
An 8  % polyacrylamide gel was prepared. The polymerized gel was then mounted upright 
in its electrophoresis chamber, which was filled with TBE buffer and allowed to "pre-run" 
for 30 minutes. To ensure an even gel temperature, an aluminium plate was clamped to 
the rear gel plate to facilitate heat transfer. Following loading and electrophoresis at 70 
W atts/ 2.5 kV, the gel plates were separated and the gel transferred to a piece of 
Whatman blotting paper and dried under vacuum at 80°C for 60 minutes. Once dry, the 
blot was placed in an autoradiography film box and exposed over night at room 
temperature. The sequence was then read and entered into the DNA Strider computer 
program for further processing.
• Polymerase Chain Reactions (PCR)
During the PCR, at least two specific oligonucleotides (or primers) anneal to a DNA 
template and are elongated by a highly temperature stable DNA polymerase. As each 
oligonucleotide anneals to a different template strand and extends towards the other - 
through succesive cycles of oligo annealing, polymerization and strand de-naturation - 
the resulting PCR product will be one or more double stranded DNA fragments that 
Incorporate the two oligos at their 5' ends.
«Standard PCR: Template DNA, PCR primers (each 0.2 pM), dNTP (20 pM), lOx 
polymerase buffer, DNA polymerase (Ip l), MgSO^ (2mM) and dH2 0  to a final volume of 
50 to 1 0 0  pi. 2  drops of mineral oil are added to prevent evaporation of the aqueous 
(lower) phase. The cycling reactions are normally separated into three stages. Stage one: 
De-naturation at 95°C for 3-4 minutes, annealing at the optimum temperature for 2 
minutes and extension for 3 minutes at 72°C. Stage two: 25-35 cycles of 1 minute at 
95°C, 1 minute at annealing temperature and 1 minute extension at 72°C. Stage three 
consists simply of an additional extension incubation at 72°C for 4-6 minutes to ensure
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that all PCR primers have been fully extended. The extension time correlates to the 
predicted length of the PCR product, while the annealing temperature is specific for the 
length and sequence of the two primers used. For specific annealing, a temperature 3 - 4° 
below the maximum should be chosen.
Depending on the PCR application, one of three different DNA polymerase enzymes 
were used. For very sensitive detection of normal sized templates (up to 2 Kb), a Taq 
polymerase was chosen. Where the PCR product was required for a subsequent sub­
cloning step, then a polymerase with proof reading such as Deep Vent DNA polymerase 
was essential. For sensitive detection and mutation-free amplification, Taq Extender was 
used. This is an optimized mixture of the standard Taq polymerase and a polymerase with 
proof reading. Polymerases with proof reading produce blunt ended PCR products, 
whereas, Taq polymerase always adds a thymidine nucleotide, in a template independent 
manner to the 3' end. Taq extender thus yields PCR products with both blunt and 
overhanging ends.
«Quick screening of mini preo colonies: Following a subcloning reaction, positive colonies 
resulting from electroporation were quickly screened using the PCR. By selecting oligos 
that annealed within the insert and/or the plasmid, the appearance and size of the 
resulting PCR product indicate not only the presence or absence of the insert, but also 
the number of inserts as well as the insert's orientation (useful if all ends are compatible).
A cocktail containing both primers (each IpM ), 1x PCR buffer, dNTPs (20pM), DNA 
polymerase, MgSÜ4 (4pM) and dH2 0  was prepared and aliquoted (20 pi) into PCR tubes. 
Using a P20 Gilson pipette with a yellow tip, bacterial colonies were picked from the agar 
amp plate, transferred to a fresh, numbered agar amp plate and then used to pipette up 
and down the 20 pi PCR volume. This innoculation was sufficient to transfer enough 
plasmid DNA for PCR amplification. The standard cycle conditions were used, allowing 
200 - 300 colonies to be rapidly screened. Maxi preps were then innoculated by picking 
the positive numbered colonies from the transfer agar amp plate.
« Site Directed Mutagenesis (SDM)
When it was necessary to introduce DNA sequence mutations into plasmids, and 
convenient restriction endonuclease cleavage sites were not available (making PCR 
difficult), the Chameleon® Site directed mutagenesis kit was used.
Two oligos were chosen. The first (mutation) oligo contained the mutation to be 
introduced. The second (selection) oligo covered and destroyed a unique restriction site 
within the plasmid. Unlike the PCR reaction oligos, the SDM oligos are 5' phosphorylated, 
annealed to the same template strand and were extended (by DNA polymerase I) in the
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same direction. This resulted in two extended primers which - through being 
phosphorylated - were able to join up to one another to create a mutated strand. This was 
digested with the restriction endonuclease, whose site was destroyed by the selection 
oligo, purified and used to transfect E.Coli (strain XL1-blue). These cells, when 
transfected with an M13 ORI-containing double-stranded plasmid, amplified only one of 
the strands as single-stranded plasmid. The template strand should, however, have been 
digested by the selection enzyme making it very much less likely to be propagated in the 
bacteria. The resulting colonies were then screened by sequencing mini preps. By 
carrying out a control reaction with Bluescript plasmid and oligos (supplied with kit), the 
success of the SDM reaction could be analysed via blue / white colony selection on agar 
plates containing X-gal and IPTG.
Oligos used for SDM had to be HPLC purified before use. Also important for the reaction 
efficiency was the choice of tube used for the XL1-Blue heat shock transfection.
• Labelling of DNA Fragments
«Radioactive: For detection of membrane-blotted RNA, 32p. labelled probes were 
prepared using the Random Primed Labelling kit from Boehringer MA. A reaction mixture 
consisting of 5 0 - 100 ng DNA, a mixture of random 6  nucleotide primers, 3 "cold" dNTPs 
and one 32p _ labelled dNTP, and dH2 Ü was heated to de-nature the template DNA. The 
temperature was then dropped to 4°C to prevent re-naturation. Klenow fragment (DNA 
polymerase) was added to the mixture which was then incubated at 37°C for 20 - 30 
minutes, until the polymerization was complete. The mixture was then passed through a 
G50 column to separate the extended oligos (labelled) from the non-incorporated free 
nucleotides. The smaller molecules are trapped in the resin's beads while the larger 
molecules move between and through the beads, exiting the column first.
The success of the labelling reaction was determined by counting 1 pi of column eluate 
using the 32p program (Chrenkow counts) in a beta counter. A specific activity of over 10® 
cpm per pg DNA was required for good, specific RNA detection.
«Non-radioactive: For detection of RNA molecules in situ a labelling reaction was carried 
out which incorporated biotinylated dUTP nucleotides. In this case the DNA was labelled 
by nick translation instead of random primer. 2 pg of plasmid DNA was incubated with 
dATP, dCTP, dGTP (each 50 pM) biotinylated dUTP (50 pM), DNase I (50 pg/ml), NT 
buffer (50 mM Tris pH 8 , 5 mM MgCl2 , 50 pg/ml BSA) and E. Coli DNA Polymerase I (20 
units) for 2 hours at 15°C and then placed on ice. During this reaction, the DNase I makes 
single-stranded "nicks" in the template DNA. The polymerase then begins to re- 
synthesize a new strand at this point and continues until the polymerase comes to a nick 
in the template strand. Here the amount of DNase I is critical as it determines the average
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length of the labelled DNA molecules. A portion of the reaction can be run on a 1% 
agarose to determine whether or not the reaction has to be extended further or not.
• Preparation of RNA from Eukaryotic Cells
Two different procedures were used to isolate two different types of RNA molecules. The 
"Total RNA" preparation was used to isolate all types of RNA from any cell type. This 
preparation worked best when the number of cells was not too high (did not exceed 
5x10®). When using total RNA to examine expression of some specific gene, it is 
important to remember that only a small percentage (approx. 1%) of the total RNA is 
messenger RNA (mRNA) which is being used to express proteins. For this reason, a 
second preparation was used which was specific for mRNA molecules. As this process 
yields only mRNA molecules, it is best to start with a very large number of cells (more than 
5x 10®).
• Total RNA Preparation. There are a wide range of total RNA kits available. The RNA- 
Clean kit (Qiagen) was used. It consists of only one solution, containing guanidinium 
thiocyanate and phenol. This is used either to resuspend a pellet of non-adherent cells or 
to scrape adherent cells down into. Cells were instantly lysed upon contact with this 
solution, the guanidinium thiocyanate protecting the RNA molecules from RNase 
degradation. Large numbers of non-adherent cells were difficult to resuspend from a solid 
pellet because of the instantaneous cell lysis. In these cases the pellet was partially 
resuspended with a small volume of PBS buffer. 200 pi of RNA-Clean buffer was used per 
million cells and the cells pipetted up and down to ensure good lysis. Chloroform was 
added (200 pi per 2 ml of homogenate), the samples vortexed for 15 seconds and then 
incubated on ice for 15 minutes. The samples were then centrifuged at 13000 rpm in an 
eppendorf centrifuge for 15 minutes. The upper phase was transferred to a fresh 
eppendorf tube and precipitated with 1 volume of isopropanol. This was incubated for 15 
minutes on ice and then centrifuged for 15 minutes at 13000 rpm, at 4°C. The 
supernatant was then removed and 800 pi 70% ethanol added to wash the pellet. This 
was repeated until no trace of phenol remained. Following the final wash, the pellet was 
briefly dried under vacuum and resuspended in 0.5% SDS or in 1 mM EDTA (pH 7). 
These solutions were prepared using DEPC- treated distilled water. OD2 6 O readings were 
not always accurate because of the presence of polysaccharides in the final RNA solution. 
The amount of polysaccharide depends on the cell type and even the stage of cell 
differentiation. To remove polysaccharide molecules, the precipitated and washed RNA 
pellet was completely resuspended in 200 pi of "RNA-Clean Extension" solution. The 
polysaccharide was preferentia lly disolved allowing the RNA to be collected via
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centrifugation (13000 rpm for 10 mins). This was then resuspended in SDS or EDTA as 
described above.
• mRNA Preparation. Initially, cells were washed twice with ice-cold PBS (magnesium- and 
calcium-free). They were then scraped down into 2.5ml (per 10cm petri dish), or 
resuspended in 1 ml (per 2x 10^ non-adherent cells) of STEPS buffer (0.1 M NaCI, 20 
mM Tris.HCI pH 7.4,10 mM EDTA, 200 pg/ml proteinase K, 0.5 % SDS) and transferred to 
50 ml Falcon tubes. The cells were homogenized using an "Ultra turrax" for 1 minute at 
speed "blue" and incubated at 50°C for 20 minutes to accelerate protein degradation. 
Next, the NaCI concentration was increased to 0.5 M and 25-50 mg of oligo d(T) cellulose 
added. This was then allowed to incubate at room temperature with shaking, overnight to 
allow the mRNA molecules to bind to the oligo d(T)- cellulose (The shaking should be 
sufficient to prevent the cellulose from sedimenting). The following day, samples were 
centrifuged (3 minutes at 2500 rpm), to pellet the cellulose. The supernatants were 
discarded, the pellets washed once, and then resuspended again in 10 ml Binding Buffer 
(0.5 M NaCI, 20 mM Tris.HCI pH 7.4, 10 mM EDTA, 0.2 % SDS). This was then loaded 
onto a filter column, the binding buffer passing through the filter leaving the mRNA- 
containing cellulose above the filter. The cellulose was then washed with approx. 60 ml of 
Wash Buffer (0.1 M NaCI, 10 mM Tris.HCI pH 7.4, 1 mM ETDA, 0.2 % SDS). Five 1 ml 
additions of Elution Buffer at 37°C were then made and the eluted mRNA collected in a 12 
ml Greiner tube. A 300 pi aliquot was removed for A2 6 O and A2 8 O spectrophotometric 
analysis. The NaCI concentration of the main RNA eluate was increased to 0.5 M and 2.5 
volumes of 100 % ethanol are added. This was allowed to precipitate at -20°C overnight 
prior to centrifugation at 10000 rpm (Sorvall RC-4 centrifuge in a HB-4 swing-out rotor) for 
30 minutes at 0°C. The supernatant was removed and the pellet briefly air-dried and 
resuspended in the required volume of dH20 or 0.2 % SDS ready for gel loading.
• Northern Blotting of RNA and labelled Probe Hybridization
To the RNA samples (8 pi) was added 4 pi of 10% MOPS, 20 pi formamide and 8 pi of 
formaldehyde (stock conc. = 37%). Samples were incubated at 60°C for 5 minutes, 
transferred immediately to ice and run on a 1% agarose gel containing 20 mM MOPS, 1 
mM EDTA, 5 mM NaAc and 6.6 % formaldehyde in running buffer consisting of 20 mM 
MOPS, 1 mM EDTA, 5 mM NaAc and 6.6 % formaldehyde, at 100 Volts. After the first 
hour, the gel was rotated 180° and the electrodes reversed. After the second hour, the 
buffer was replaced.
Following electrophoresis, the gel was removed and allowed to shake in 50 mM NaOH, 10 
mM NaCI for 20 minutes. This acts to break the RNA molecules up into smaller fragments
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which allows an efficient transfer to the support membrane. The gel was then washed with 
shaking in 20x SSC (3M NaCI, 0.3M sodium citrate pH 7) buffer 3 times, each 15 minutes. 
The RNA fragm ents were transferred (blotted) to a positive ly-charged nylon 
"Genescreen" membrane overnight using 20x SSC as transfer solution. The following 
day, the membrane was washed in 2x SSC to remove any contaminating agarose, dried 
and baked for 2 hours at 80°C under vacuum. This ensures that the RNA fragments are 
firmly attached to the membrane.
Prior to the addition of 33p labelled probe, the membrane was "pre-hybridized" in Church 
buffer (0.5 M NaHP04 pH 7.2, 1% BSA, 1 mM EDTA, 7 % SDS) for between 15 minutes 
and 2 hours with shaking (or rotation). This buffer was removed and replaced with 7-10 ml 
of fresh pre-warmed (65°C) Church buffer. To this was added the labelled DNA probe 
following after having been heated to 95°C for 5 minutes and cooled on ice. The 
hybridization process at 65°C with shaking was continued overnight. The following day, 
the membrane was washed 3 times for 15 minutes in wash buffer (1 % SDS, 1x SSC) at 
65°C and once in stringent wash buffer (1% SDS, 0.2x SSC) at 65°C. In this way non- 
specifically bound labelled probe should be removed. The membrane was wrapped in 
cling-film and placed in an autoradiography box with a film to expose for 60 minutes. This 
film was then developed to determine whether the membrane had to be washed further 
to remove excesive background or needed a longer exposure time.
• cDNA Synthesis for RT-PCR
In order to study gene expression at the RNA level via RNA prep and Northern blot, a 
large number of cells are required . In situations where too few cells are available or a quick 
check (before Northern analysis) is neccesary, it is possible to use the PCR reaction to 
specifically amplify the "transcript" of interest. Because PCR can not be performed using 
RNA molecules as template, DNA copies of the RNA molecules must first be made. This 
is done by using the Reverse Transcriptase (RT) enzyme from Murine Leukaemia Virus to 
extend an oligo(dT) primer which hybridizes to the poly(A) tail at the 3' end of all 
processed mRNA molecules. cDNA molecules are thus extended until the cap structure 
at the 5' end of the transcripts is reached. These cDNA molecules can then be used as 
template in a standard PCR.
cDNA (and the subsequent PCR) was made using the GeneAmp® kit from Perkin Elmer. 
1 pi of total RNA was added to a reaction mixture containing; MgCl2 (5mM), 1x PCR buffer 
II, 2 pi DEPC treated water, dATP, dCTP, dGTP and dTTP (each Im M ), RNase inhibitor 
(lU /p l), MuLV Reverse Transcriptase (2.5 U/pl), Oligo d(T)ie  (2.5 pM). The total volume 
was 20 pi. This was allowed to incubate for 10 minutes at room temperature allowing the
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oligo d(T) to anneal and partially extend. The reaction was then incubated at 42°C for 15 
minutes for complete reverse transcription. The RNA-DNA complexes were de-natured 
upon incubation at 95°C for 5 minutes and placed immediately on ice.
Prior to PCR, 78 pi of a mix containing 2 mM MgCl2 , 1x PCR buffer II and 2.5 Units/100 pi 
AmpliTaq® DNA polymerase and 1 pi of each primer (final concentration of 0.15 pM) was 
added and the 100 pi mixture gently mixed. A single drop of mineral oil was added and the 
tube placed in a thermocycler (Stratagene Robocycler). For cycle conditions - see 
standard PCR method.
• Sterile Cell Culture Techniques
Prior to starting work, the UV lamps were switched off, and the air-flow system switched on 
and allowed to equilibrate. Then the front panel was then raised to the 20 cm mark. Latex 
gloves were worn at all times. These were sprayed with ethanol and allowed to air-dry 
before medium bottles etc were picked up. Before bottles of culture medium , pipette 
holders etc were placed into the hood, they were first sprayed with ethanol and allowed to 
air dry inside the hood. A cell culture bunsen burner was kept at a low yellow flame for the 
entire working time. Before opening and after closing sterile bottles and other containers, 
the the opening was briefly flamed (blue flame) without being allowed to become too hot. 
Sterile glass pipettes were used for almost all pipetting, these were passed through the 
flame before use. Disposible plastic pipettes were used when pipetting virus-containing 
media. Bottles or tubes with sterile contents were not left open for longer than neccesary, 
the tops being held in the hand when possible. All waste which, during the course of 
work, became contaminated with media, cells or supernatants was autoclaved. After 
finishing work, all items were removed from the hood. The bunsen was turned off, the 
stainless steel and glass surfaces were sprayed with ethanol and wiped dry. The door was 
closed, the UV lamps were swithed on and the air flow switched off.
• Passaging ("Splitting") of Adherent and Non-adherent Cells
Adherent cells were first washed once with sterile PBS medium (1.3 mM NaCI, 2.5 mM 
KCI, 10 mM Na2 HP0 4 , 1.8 mM KH2 PO4  pH 7.4). Depending on the level of adherence, 
there was then added either PBS containing 5 mM EDTA (for normally adherent cells) or 
PBS containing 5 mM EDTA and 0.25% Trypsin (for highly adherent cells). The cells were 
examined under the microscope for signs of cells becoming less adherent (rounding up). 
Before the cells started coming away from the plastic, the PBS was removed via aspiration 
and the cells taken up in 10 ml of culture medium. For adherent cells this was DMEM with
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either 5% or 10% PCS added. The cells were pipetted well to obtain single cells before a 
10 |il aliquot was removed for cell counting using a hemocytometer. C 0S7 cells were split 
1:10 every three days. Mouse fibroblast cell lines were split 1:5 every two to three days. 
The frequency and density of splitting depended upon the growth characteristics of the 
individual cell lines. Lines which tended to form colonies could not be split too sparsely or 
left too long without being split again. The required number or portion of cells was then 
pipetted into a new culture bottle, which then had extra, fresh DMEM added to it. 
Non-adherent cells were either grown in medium-sized culture bottles or in large (2L) 
roller bottles. After a 10 pi aliquot had been counted, the required volume of cell- 
containing medium was removed and centrifuged at 1600 rpm in a Heraeus centrifuge for 
5 minutes. The supernatant was carefully aspirated off and the cell pellet resuspended in 
fresh culture medium, which for non-adherent cells was typically RPMI with 5% PCS 
added. It was not always neccesary to centrifuge a portion of cells down and resuspend 
then again in fresh medium, but this did help to remove any dead cells which do not 
sediment as quickly as living cells.
For both processes, the PBS and culture media were pre-warmed to 37°C to avoid heat 
shocking the cells. Cells were grown in incubators at 37°C with 6 % CO2 .
• Freezing and Thawing of Cells into and out of Liquid Nitrogen
Before being frozen, cells were kept continuously in growth phase. 5 million cells were 
centrifuged down at 1600 rpm for 3 minutes and resuspended in 500 pi of PCS 
containing 10% DMSO. This was swiftly transferred to a pre-cooled (4°C) freezing tube 
and placed immediatly at -70°C. After 2 days at -70°C the tube was then moved quickly to 
liquid nitrogen (-180°C) storage. DMSO in solution is extremely toxic for the cells, thus it 
was often preferred to first pipette the DMSO into the freezing tube and then to add to 
this the cells in PCS.
When thawing cells, it was very important that the thawing time be minimized. The frozen 
tube was transferred from liquid nitrogen to a 37°C waterbath until its contents had 
thawed. The contents of the tube were then mixed with 10 ml of fresh medium and 
centrifuged at 1600 rpm for 5 minutes. The supernatant was then removed and fresh 
medium added and used to resuspend the cells. These were then transferred to a 
medium-sized culture bottle and incubated at 37°C.
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• Calcium Phophate Transfection of Adherent Ceiis
2 0  hours before transfection, cells were seeded into 1 0 cm petri dishes at a density which 
ensured that after 3 days of normal growth, the cells would again be ready for splitting. For 
COS7 cells, 3x 10®  cells were seeded whereas for Hela cells, 5 xIO® were required. For 
Fluorescence in-situ hybridization analysis (FISH), COS7 and Hela cells were seeded at 
densities of 7.5 xIO^ and 10® cells per microscope slide, respectively. 4 hours before 
transfection, the medium (DMEM 10% FCS) was changed.
The DNA (20-30 pg) was pipetted into a 12 ml plastic tube tube with 50 pi of sterile 2.5 M 
CaCl2 and made up to 250 pi with sterile dH2 0 . To this was added (dropwise) 250 pi of 2 x 
BES buffer (10.7 g/L BES, 250 mM NaCI, 2 mM Na2 HP0 4  pH 6.96). The 2x BES buffer 
was added using a P200 pipette (Gilson), held in one hand whilst a Sarstedt pipette-aid 
and pasteur glass pipette were held in the other and used to bubble air through the 
solution from the bottom of the plastic tube. This was found to result in a very fine 
precipitate (visible using a light microscope) upon mixing of the two solutions.
This solution was incubated at room temperature for 30 minutes with occasional gently 
mixing and then pipetted (dropwise) on to the plated cells. Fresh medium was not added. 
Cells were incubated for 12-14 hours at 37°C and then washed well with sterile PBS to 
remove as much precipitate as possible. Fresh medium was added and the cells allowed 
to incubate again at 37°C for up to 2 days or until confluent.
• DEAE-Dextran Transfection of Non-adherent Cells
10 million cells per transfection were centrifuged down in 250 ml Corning centrifuge 
bottles at 1600 rpm for 10 minutes at 4°C. The supernatant was removed via aspiration 
and 2  ml of TBS buffer (25 mM Tris pH 7.4, 137 mM NaCI, 5 mM KCI, 0.7 mM 
CaCl2 .(H2 0 )6 , 0.5 mM MgCl2.(H20)6, 0 6  mM Na2 HP0 4 ) added per transfection. After 
being carefully resuspended in TBS, the cells were aliquoted (2ml) into 5 ml plastic tubes. 
These were then centrifuged in a table top centrifuge for 2 minutes at 2000 rpm to pellet 
the cells. The supernatant was again removed via aspiration.
The DNA to be transfected was pipetted into a 5 ml plastic tube. The volume was made up 
to 250 pi with TBS buffer. To this was added a 250 pi mixture of TBS containing 1 mg/ml 
DEAE-dextran and 40 pg/ml chloroquine. This 500 pi volume was used to resuspend the 
cell pellet. After a 30 minute incubation at room temperature with occasional gently 
mixing, 2 ml of fresh TBS was added to each tube and the tubes centrifuged again to 
pellet the cells. The pelleted cells were then resuspended in RPMI medium (5% FCS) and 
transferred to a medium-sized culture bottle. The cells were incubated for 48 hours 
before being harvested and processed further.
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N.B. The chloroquine used was taken from a freshly prepared 4 mg/ml stock solution. 
Chloroquine acts to reduce endosomal degradation of the endocytosed DNA-dextran 
complex.
• Electroporation of Eukaryotic Ceils
Sterile electroporation cuvettes with a 0.2 cm electrode gap were pre- cooled on ice. The 
DNA (20-30 pg) was precipitated in 0.15 M NaAc and 2 volumes of 100% ethanol. After 
washing with 500 pi of 75% ethanol, the DNA was resuspended in 20 pi of sterile PBS. 
Cells were washed once in PBS and then centrifuged and resuspended so that 180 pi of 
PBS would contain 2 million cells. The DNA was added to this and the mixture carefully 
pipetted and transferred to the pre-cooled cuvettes, on ice.
The electroporation apparatus (Bio-rad Gene Puiser) was connected to the capacitance 
controller (Bio-rad) and set to : 0.26 KV, 960 pF with "external" selected. The cuvette 
holder was connected to the capacitance controller (external). The contents of the 
cuvette were then briefly mixed and the cuvette placed into the holder. The cells were 
pulsed and the cuvette placed on ice for 1 0  minutes before the cells were taken up in 
fresh medium and transferred to a culture bottle and incubated at 37°C. When transferring 
the electroporated cells to the culture bottle, the large mass of dead (lysed) cells was 
removed using the end of a blue pipette tip. Presence of too many dead cells in the fresh 
medium inhibits the growth of surviving cells. The electroporation protocol was optimized 
for use with C0S7 cells - resulting in an efficiency of approximately 40 %, assayed via X- 
Gal staining of cells transfected with a p-galactosidase expressing plasmid. Approximately 
50 % cell death occured at the optimum conditions.
N.B. It is also possible to use medium instead of PBS as the electroporation medium - in 
the case of C 0S7 cells this was not advantageous. Cuvettes were washed after use with 
distilled water, then 1% SDS, then water again and finally 75% ethanol. They were then 
stored under 75% ethanol at room temperature.
• (3-Galactosidase Expression Assays
Three different assay methods were used. (i). The standard assay, in which the cells were 
fixed (and therefore died) involved the use of the X- Gal (5 Bromo-4-Chloro-3-indolyl-p-D- 
galactoside) substrate. Here the cells were washed once in PBS and fixed used ice- cold 
fixing solution (2% formaldehyde and 0.2% glutaraldehyde in PBS). The cells were 
incubated for 10 minutes in fixer at 4°C and then washed three times with PBS to remove 
the fixer. Pre-warmed (37°C) staining solution (5 mM potassium ferrocyanide, 5 mM
Methods 41
potassium ferricyanide, 2 mM MgCIa in PBS) with 100 pi X- Gal (stock 20 mg/ml in Di- 
methylformamide) per 4 ml added, was added to the fixed, washed cells. This was 
incubated at 37°C overnight. Depending on the level of expression, it was often possible 
to observe blue staining after 2-3 hours. The X- Gal aliquots were stored at -2 0 °C in 
darkened tubes until required.
(ii) When it was necessary to keep the stained cells alive, for example to sort via 
Fluorescence Activated Cell (FAC) sorting, the substrate FDG was used. In this protocol, 
cells were washed once with sterile PBS and then resuspended in PBS at a 
concentration of 10 million cells per ml. To this was added chloroquine to a final 
concentration of 300 pM and the mixture put on ice. A 100 pi (10® cells) aliquot was then 
removed and incubated at 37°C for 20 minutes. 100 pi of pre-warmed FDG (in dH2 0 ) was 
then added and quickly and mixed well. This was incubated at 37°C for 60 seconds only. 
During this step, the FDG was taken up by the cells as they swelled due to osmosis. To 
prevent cell death, 1.8 ml of ice-cold isotonic solution (1 pg/ml propidium iodide in PBS) 
was added. The cells were then put back on ice for 5 minutes. PETG (Im M  final conc.) 
was then added to stop the FDG leaking back out of the cells. The cells were then 
analysed using a FAC scan machine. Cells able to convert the FDG (and thus containing 
the p-galactosidase protein) were fluorescent. Propidium iodide allowed the visualization 
of the dead cell population. By selecting the population of cells that were FDG positive 
and PI negative, a readout of percent positive cells was obtained. This "gated" area was 
then sorted to give only the live, transfected cells. These cells were put back in culture, 
expanded and assayed again until a 1 0 0 % transfected population was obtained.
(iii) Plasmids expressing the Lac Z gene were co-transfected and assayed as in internal 
control for transfection efficiency. This was done on occasion as part of the assay for 
Chloramphenicol Acetyltransferase (CAT) protein. In this situation, to a portion (30 pi) of 
the lysate derived from transfected cells was added 500 pi assay buffer and 100 pi of 
ONPG (2 mg/ml). This was incubated at 37°C for 2-3 hours (or until a yellow colour became 
visible). At this point 250 pi of 1 M Na2 C0 3  was added to stop the reaction. The optical 
density was then measured at 420 nm.
• Chloram phenicol Acetyltransferase (CAT) Expression Assay
Transfected cells were harvested after 48 hours incubation at 37°C and washed once with 
PBS. The cell pellet was resuspended in 100 pi of 250 mM Tris (pH 7.4) in a "safe-lock" 
eppendorf tube. The cells were then freeze-thaw lysed by placing the tube in liquid 
nitrogen for 2 minutes and then at 37°C for 5 minutes. This was repeated three times. The 
tube was then centrifuged at 14000 rpm at 4°C for 5 minutes. The supernatant was then
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transferred to a fresh eppendorf tube. Either a (3-gaiactosidase assay was carried out (if a 
LacZ plasmid had been co-transfected) using 30 pi of supernatant or a total protein assay, 
using 1 pi supernatant. To determine total protein content, the Bio-rad Protein Assay 
solution was diluted 1:5 and added to the 1 pi supernatant. The optical density at 595 nm 
was then measured. The remaining supernatant was incubated at 65°C for 10 minutes, 
then centrifuged at 14000 rpm for 5 minutes at 4°C. Again the supernatant was pipetted 
into a fresh eppendorf tube and placed on ice.
A reaction "cocktail" was then prepared which consisted of 4 p l/sam ple ‘' ^ c -  
Chloramphenicol, 0.67mM Acetyl CoA, 250 mM Tris pH 7.5 and dH2 0  up to a volume of 
1 2 0  pi per sample and kept on ice.
After analysis of the OD595  values (or OD4 2 0 ), an equal amount of total protein containing 
(or [3-galactosidase expressing ) lysate was pipetted into a fresh eppendorf tube for each 
sample. The volumes were standardized such that the lysate of lowest activity had a 
volume of 30 pi and from all others a smaller volume of lysate was taken. The difference in 
volume was compensated for by addition of 250 mM Tris up to the 30 pi volume. To the 
30 pi volumes was then added 120 pi of "cocktail". The tubes were then mixed carefully 
and incubated at 37°C for 60 minutes. 800 pi of ice-cold ethylacetate was then added to 
each sample. This was vortexed well and then centrifuged at 13000 rpm for 10 minutes. 
The upper layer was then transferred to a fresh eppendorf tube and dried in a vacuum 
drier for 4 5  minutes. 30 pi of cold ethyl acetate was then added and the tube shaken in an 
eppendorf shaker for 1 0  minutes to ensure good solution of the chloramphenicol 
desicate. 30 pi samples were then loaded onto a thin layer chromatography sheet which 
was then placed in a chromatography tank containing a mixture of chloroform (190 ml) and 
methanol (10 ml). This mixture had to be prepared at least 2 hours in advance to allow 
equilibration of the solvent mixture. Normally it was possible to re-use the solvent at least 
5 times. When the solvent front had run about 90 % of the TLC, the TLC was removed, 
allowed to air dry and was then placed in an autoradiography box. A film was then placed 
inside and allowed to expose overnight.
Films were then scanned using an Apple Macintosh computer and Adobe Photoshop 
version 3.0 . Regions of interest were selected and then copied into Deneba's Canvas 
version 3 .5  program, where they were further processed (addition of sample names and 
acétylation values). Acétylation values were measured using a l^C -counter (Berthold 
Tracemaster 20 automatic TLC-linear analyzer) which scanned the TLC in the vertical 
direction starting from the loading point. The number of counts per second at different 
positions along the vertical line was then plotted. This way values for non-acetylated and 
the different mono-acetylated forms of ^^Chloramphenicol could be obtained and a 
percentage acétylation calculated.
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• Fluorescence in -s itu  Hybridization (FiSH)
This technique was used to visualize specific RNAs in the two main cellular compartments 
(nucleus and cytoplasm). First, cells were transfected via calcium phosphate precipitation 
on poly-L-Lysine (4mg/ml) coated "Superfrost" m icroscope slides in 4-cham ber 
"Quadriperm" tissue culture plates.
Fixing & Permeablizina of cells: Cells were washed three times with PBS and then fixed in 
4% paraformaldehyde (freshly prepared) for 20 minutes at room temperature. After 
another wash in PBS, cells were partially permeabilized by incubation in STPBS (0.5% 
saponin (w/v), 0.5% Triton X-100 (v/v) in PBS) for 20 minutes at room temperature. The 
cells were then washed once more in PBS and then incubated in 20% glycerol for at least 
30 minutes. Slides were then removed, frozen in liquid nitrogen. If not being directly 
further processed then the slides were stored at -70°C. If continuing, then the cells were 
removed from the liquid nitrogen and allowed to thaw very slowly at room temperature 
before being placed in PBS prior to the dénaturation step.
Labelling, precipitation & dénaturation of probe DNA: Construct J258 was used to 
prepare a CAT probe and the CMV-LacZ plasmid was used to prepare a LacZ probe. 
Probes were labelled by nick translation using biotin-11-dUTP or Digoxoginin-11-dUTP in 
place of dTTP (see non-radioactive labelling). The average length of the probe molecules 
(200 nt) was checked on a 1% agarose gel (containing ethidium bromide). Probe DNA 
(200-400 ng per slide) was precipitated together with 7pg of salmon sperm DNA , 3|ig of 
human C0T1 DNA by 0.05 volumes of 3M sodium acetate and 2 volumes of 100% 
ethanol. This was incubated at -80°C for at least 30 minutes before being pelleted via 
centrifugation at 13000 rpm in an eppendorf centrifuge for 15 minutes. The pellet was 
washed twice with 500 pi of 70% ethanol and allowed to air-dry. It was then resuspended 
in a solution of 50% deionized formamide, 2x SSC, 10% dextran sulphate and 50 mM 
sodium phosphate.
The probe mix was denatured at 75°C for 5 minutes and then placed at 37°C to allow the 
C0T1 DNA to anneal to any repetitive (GC rich) sequences.
Denaturing of cells: Cells were denatured in 40% formamide, 2 x SSC (pH 7.0) at 73°C for 
3 minutes. At this concentration of formamide, only RNA molecules are de-natured (not 
DNA). To verify that signals seen were not from DNA, an RNase digestion was made in 
parallel (1 OOpg/ml RNase A).
Hvbridizing & washing: The denatured probe and cells were then incubated together (by 
placing the coverslip (containing probe) on top of the cells (on the slide)) at 37°C for at 
least 12 hours in a humidified chamber to prevent probe evaporation. The following day, 
the slides were washed three times (each 5 minutes) with low stringency buffer (50% 
formamide, 2x SSC, pH 7.0 at 42°C) and then three times (each 5 minutes at 42°C) with
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high stringency buffer (0.1 x SSC pH7.0 at 60°C). Cells were then incubated in a solution 
of 4x SSC containing 4% BSA for 20 minutes at room temperature.
Detection of probe: Probe was detected using either fluorescein conjugated avidin or 
fluoresein conjugated sheep anti-digoxoginin antibody. This was carried out using a 
solution containing 4x SSC and 1% BSA. A 10 minute incubation with propidium iodide (2 
pg/ml) was made to enable visualization of cell nuclei.
Analvsis of staining: Confocal laser scanning images were aquired on a Zeiss confocal 
laser scanning microscope (LSM 310) equipped with an argon ion laser and a helium 
neon laser using an oil immersion 63x plan-APOCHROMAT lens (Zeiss). Red (propidium 
iodide) and green (fluorescein) images were simultaneously obtained by exitation of 
rhodamine and fluorescein at 488 nm.
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SECTION A: Sub-Cloning of HTLV-I based Constructs
• Cloning of the LTRj a y  vector
Initially, a vector (LTRjay-HCB.LTR) was constructed using plasmids from two sources: (i) The 
pHTLV-tat I construct (Nerenberg et al. 1987) and (ii) Derivatives of pHTLV-tat I cloned by K. Sach 
(1991) which contained the Murine Leukaemia Virus (MLV) extended psi sequence and the pgk- 
Neo cassette, both from pHMB (Hawley et al. 1989; Bender et al. 1987). Fragments from these 
constructs were cloned together into the Bluescript II SK+ phagemid which contains a large number 
of unique restriction sites and allows the production of single-stranded DNA through the use of fd 
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Figure 5. Cloning procedure for reconstruction of the L T R j a y  vector (J157) inside 
Bluescript I I  SK4-. The 1.7 kb Xho I- Hind III 5'LTR-psi fragment was cloned first. This 
consisted of a fusion between the H TLV-I 5'LTR and the M LV extended packaging sequence 
(nt. 165 to 1037 of M LV  sequence). Next the HTLV-tat 1-derived 180bp Scal-Bam HI 
fragment was cloned into EcoRV-Bam HI. This reconstituted the first part of the 3'LTR (up 
until the site of the old Aat II ). The remaining 600bp was inserted as a blunted Aat II- Sac 1 
fragment into the blunted Xba I-Sac I sites. This fragment was cloned from pUC18.tax.3'LTR 
after deletion of the BamHl-Bgl II fragment. Finally, two oligos (#11 and #12) were annealed 
to one another and inserted into the unique Hind 111 site. This resulted in the insertion of a Cla 
1 and a Bgl II site as well as maintaining one of the Hind 111 sites - the other being mutated. 
The multiple cloning site orientation used was the Hind 111-Cla 1-Bgl 11 (HCB) orientation.
Results 46
Construct J157 was sequenced, the 5'LTR sequence is shown below:
1
TGACAATGAC CATGAGCCCC AAATATCCCC CGGGGGCTTA GAGCCTCCCA  
GTGAAAAACA TTTCCGCGAA ACAGAAGTCT GAAAAGGTCA GGGCCCAGAC 1 0 0  
TAAGGCTCTG ACGTCTCCCC CCAGAGGACA GCTCAGCACC GGCTCAGGCT 
AGGCCCTGAC GTGTCCCCCT GAAGACAAAT CATAAGCTCA GACCTCCGGG 2 0 0  
AAGCCACCAA GAACCTCCCA TTTCC TC CC C  A TG TTTG TC A  AGCCGTCCTC  
AGGCGTTGAC GACTAACCCC TCACCTCAAA A A A C TTTTC A  TGGCACGCAT 3 0 0  
ATGGCTGAAT AAACTAGCAG GAGTCTATAA AAGCGTGGAG ACAGTTCAGG  
AGGGGGCTCG C A TC TC TC C T TCACGCGCCC GCCGCCCTAC CTGAGGCCGC 4 0 0  
CATCCACGCC GGTTGAGTCG CGTTCTGCCG CCTCCCGCCT GTGGTGCGTC  
CTGAACTGCG TCCG CCGTCT AGG TAAG TTT AAAGCTCAGG TCGAGACCGG 5 0 0  
G CCTTTG TCC GGCGCTCCCT TGGAGCCTAC CTAGACTCAG CCGGCTCTCC  
ACGCTTTGCC TGACCCTGCT TGGTGTA CA T CGTGTCTGCG T C T A T T C T G T  6 0 0  
T T T C A G T T C T  T C TG T TT C T G  TCG CCTACTA GTCCACTCTC AGGAGAGAAA 
T TTA G TA C A  C A . T  6 7 2
Figure 6. 5' LTR  sequence of construct J157. The sequence extends from the 5' end of the 
U3 region (bold) to the integration region (bold, underlined) at the 3' end of the U5 region.
The expected deletion inside the U5 region was seen to extend from bp 575 and continue up 
until bp 727 of the published sequence (Accession # J02029). A 58bp insertion of unknown 
origin was sequenced (underlined) and seen to be G-T rich in nature. A single "G" deletion 
was observed at the integration region, however, as infectious virus had been successfully 
produced from constructs with this deletion, it was thought unlikely to play an important role.
These LT R jay  vectors have the ORS region (Seiki et al. 1990) deleted and should allow LTR- 
driven expression in a Rex-independent manner. The observed U5 insertion may have been made 
to reconstitute the poly A site. In addition to expression from the LTR jay  constructs, we were also 
interested in expression from the "full length" LTR7 5 5 . It was therefore decided to insert a full 
length LTR in place of the mutated JAY LTR.
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• Cloning of the Full Length LTR7 5 5  vector
A second series of vectors was cloned which contained the full length (755bp) 5' LTR attatched to 
the MLV extended packaging sequence (ext. psi). To this aim, both the new 5' LTR and the 
extended psi sequence were PGR amplified independently, using the 3' LTR from pHTLV tat1 and 
pHMB, respectively, as templates. Both PGR products were then used as templates in a third PGR 
reaction which resulted in "ligation" of the two fragments (fig.7).
PCR react b  n A; prim ers 1 & 2 
PCR reaction B: primers 3 & 4 





PCR product Xho I 
0-
5 ' LTR Hind I
ext. psi
Figure 7: PCR construction of 755bp 5' LTR. Due to the nature of oligos 2 (#29) and 3 (#92), 
there was a 16bp overlap at the 5' ends. The maximum annealing temperature of the 16bp 
overlap was chosen to be 2° lower than that of the two amplifying oligos (63° and 65° 
respectively). This slight difference promoted the annealing of the two template molecules to 
each other before the reaction three amplifying oligos (#91 and #11) could anneal and thus 
maximized the yield of full length PCR product (1.7kb). *See Materials section for 
oligonucleotide sequences.
The Xho I - Hind III fragment was then cloned to produce two different constructs (fig.8 ).
/ deletion (620-727) Bam HI
5'LTR psi+  Z -A  3'LTR 
HCB
J195






Figure 8 . Cloning of the new LTR-psi fragment (Xho I- Hind III) . This was done in 
construct J157 (to yield construct J195) as well as one of the cloning intermediates (J114a) to 
yield construct J193. See section D for details of cloning intermediates.
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J193 was sequenced as there was no chance of the sequencing primer (#20) annealing to both 
LTRs. The sequencing showed that the deletion / mutations present in the JAY LTR were no 
longer present. DNA sequencing later revealed that the sequence of the PCR product cloned to 
create J195 was not the same as that of the first sequenced J193! While J193 contained the full 
length LTR7 5 5 , J195 contained a deleted LTR. The deletion was again seen to be present in the 
U5 region and it was suspected that the PCR "product" contained both full length (755bp) LTRs 
and US-deleted (628bp) LTRs. The formation of secondary structure within the US region during 
the PCR could have produced such a phenomenon. Closer examination of the sequence of the 
J19S LTR showed that the oligos used in the PCR protocol (#91 & 29) were present and that the 
deletion was from bp S76-703. This removed the entire CRS region (described by Seiki et al. 1990) 
without disturbing the C/s-activating Sequences (CAS) (Kashanchi et al. 1993) which are required 
for basal expression from the HTLV-I LTR. The larger deletion present in LTRj a y  removed not only 
the CRS but also 4S% of the CAS element. For this reason, the J19S mutant was used as a CRS' 
LTR, termed LTReas in subsequent experiments.
A construct consisting of two 755bp LTRs (J225) was then cloned by inserting the 3'LTR into the 
J193 construct as a Bam HI - Sac I fragment. This Bam HI site was created by Kerstin Sach by 
cleavage and blunting of the existing Aat II site in the U3 region and ligation of Bam HI linkers.
















Figure 9. Cloning of construct J225. The Bam Hl/Sac I fragment was removed from 
construct J195 and inserted into J193.
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• Insertion of the PGK promoter-Neomycin Resistance Cassette - DC Vectors
The PGK- Neo cassette was derived from the pHMB construct. It was cloned as a BamHI fragment 
into the BamHI site in the 3'LTR .
By placing the second gene (Neo) inside the 3'LTR, it was thus hoped to overcome the 
phenomenon of promoter silencing.
755
J225













n^ j Neo # a _ J  J206
Figure 10. Insertion of the 1.35 Kb PGK-Neo Bam HI fragment to give DC (Double Copy) 
vectors having either a complete (755bp) 5'LTR or the CRS deletion (LTR628)-
• PCR cloning of the Chloramphenicol Acetyltransferase (CAT) reporter gene
To examine the expression levels from the two different LTRs a suitable reporter gene had to be 
chosen. The CAT gene offers a very sensitive readout of LTR expression which can be quantitated 
very accurately by performing a CAT assay. In the CAT assay, lysates of transiently transfected cells 
are added to a cocktail containing ^^C-labelled Chloramphenicol and Acetyl Coenzyme A. The 
Chloramphenicol is acetylated by CAT enzyme from the lysates and then migrates more rapidly on 
thin layer chromatographs (TLCs). The relative percentage of acetylated Chloramphenicol can then 
be quantitated using a "^^C detector.
A suitable CAT gene with the correct cloning sites was not available, so once again a PCR was 
performed. The primers (see materials for sequence) contained restriction sites for Hind III and Bgl II 
and amplified the CAT gene from the plasmid pBL-CAT2 (Luckow and Schütz 1987). The PCR was 
optimized to minimize mis-incorporations. Deep Vent® DNA polymerase (NE Biolabs) was used in a 
16 cycle reaction with 4mM Mg2+. PCR products were cloned directly into the recipient plasmids 
(fig.11 ) and then sequenced using the PCR oligos (#101 & 102). For each of the four plasmids, two 
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Figure 11. Double-copy and standard C A T expression vectors. After being PCR 
amplified, the CAT PCR product was digested with Hind I I I  and Bgl II. This was then 
inserted into each of the four constructs pictured in fig. 10 to yield the above constructs.
The resulting constructs (J243, J244, J245 & J246) were then used in transient transfections of 
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Figure 12. C A T expression Assay of single and double copy C A T vectors. Cell lysates 
were made from Jurkat cells 48hrs after DEAE transfection of 5pg of each CAT expression 
construct. CAT assays were performed using total protein concentration to standardize lysate 
volumes between samples. CAT expression was seen from both the CRS-containing and CRS- 
deleted constructs upon co-expression of Tax alone (J245 & J243, lane 2). Percent conversion 
of Chloramphenicol is shown for each reaction (boxed).
From this experiment it was clear that the PGK-Neo cassette insertion although not removing CAT 
expression, did reduce it. As constructs J245 and J246 contain the CRS, it was expected that CAT
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expression from these constructs, relative to constructs J243 and J244, would be very much lower. 
Interestingly, the expected repression of CAT expression upon Tax transactivation alone was not 
observed in these LTR7 55  constructs.
Optimizing levels of Tax and Rex frans-activation
The amounts of Tax and Rex appear to be critical -1 pg of Tax plasmid together with not more than 
1pg of Rex plasmid led to the best CAT expressions. This experiment was repeated with constructs 
J243 and J245 to determine the optimal amounts of Tax and Rex plasmids for co-transfection (see 
fig. 13).
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Figure 13. Optimization of co-transfection. 5pg of either J243 or J245 was transfected with 
increasing amounts of Tax and Rex expressing plasmid into Jurkat T cells. Lysates were made, 
standardized for total protein concentration and assayed for CAT activity.
This experiment clearly showed that the optimum amounts of Tax and Rex plasmid to be co­
transfected with 5pg of CAT reporter were Ipg  and 0.1 pg, respectively. The reduction of CAT 
expression upon increasing levels of Rex plasmid was thought to be due to the fact that both the 
Tax and Rex expressing plasmids use a CMV promoter. The availability of transcription factors for 
CMV-Tax expression is reduced if the amount of CMV-Rex plasmid is increased (squelching (Gill 
and Ptashne 1988)). This was tested by transfecting increasing amounts of a control CMV plasmid 
(results not shown) and indeed, the level of Tax frans-activated CAT expression was reduced upon 
addition of plasmid CMV-ER (where ER is the cDNA for the hormone binding domain of the human 
Oestrogen receptor). The reduction in CAT expression upon addition of increasing levels of Rex is 
thus due to promoter competition and not Rex itself, and is ignored in subsequent experiments.
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After characterization of the unexpected mutation within the U5 region of construct J195 it was 
necessary to re-check construct J245 by DNA sequencing to ensure that the CRS was still present. 
The DNA was complete. Detailed comparison of our constructs with those of Seiki & Yoshida - who 
have shown that constructs with two full length LTRs do not express upon Tax frans-activation 
alone - revealed that the only significant difference was the presence of the MLV extended 
packaging signal, in our vectors. This is because the constructs were initially designed with the aim 
of producing MLV pseudotyped HTLV-I based virus. It was decided to remove the psi sequence to 
test whether it had been responsible for the unexpectedly high level of expression.
• Removal of the MLV Extended Packaging Sequence
Hind 111 LTR 755 LTR628
Xho I Xho Xho
psi
J245
(  PCR with Vent ® 









Figure 14. Deletion of the extended psi sequence. Removal of the 5'LTR-psi sequence from
construct J245 via Hind III  digestion, blunting and digestion by Xho I, was followed by Vent 
Polymerase PCR of Full length and CRS" LTRs (The Vent polymerase used contained a proof 
reading activity and therefore produced a PCR product without 3' overhangs). These PCR 
products were then digested with Xho I to give one sticky and one blunt end, and ligated back 
into the prepared J245 vector backbone. This resulted in the destruction of the original Hind 
III.
Following a sequencing check (oligo #20) of the two newly amplified 5'LTRs, the constructs (J258 
& J259) were used to transfect Jurkat T cells. Tax and Rex expressing plasmids were co­
transfected. Lysates were made and assayed for CAT activity.
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% A cet yla t ion
Tax (pg ) 
Rex (pg )
J 2 5 9J258
Figure 15: CA T expression assay of full length and CRS" constructs following psi 
deletion. Lysates were made 48 hours after transfection with 5pg of CAT plasmid DNA, 
standardized for total protein and assayed for their CAT activities. Removal of the psi sequence 
allowed the CRS effect to be seen. Expression from construct J258 was repressed (lane 2) 
whilst expression from the CRS" construct (lane 6) was significantly higher. Addition of Rex, 
however, led to a further increase in expression (lane 7).
Observation One: The HTLV-1 LTR encodes a second negative regulatory element
Construct J258 was then seen to be highly Rex dependent (fig. 15 compare lanes 2 and 3). Upon 
expression of Tax, CAT activity was completely repressed. This was presumably due to the nuclear 
retention function of the CRS.
Tax frans-activation of construct J259 (CRS") allows a low level of CAT expression, but is also highly 
Rex inducible. Although CAT expression increases to 5.4%, the repression present in J258 is not 
completely removed. After removal of the CRS, Rex was still able to give a 14-fold enhancement 
(lane 7).
The fact that removal of the CRS from the 5'LTR did not result in a complete removal of repression 
indicated that there was another negative element present in construct J259. It had recently been 
shown that the HIV Rev response element (RRE) contains a negative element (Brighty and 
Rosenberg 1994) in addition to the well characterized positive element . This element led to the 
retention of transcripts in the nucleus. For this reason we decided to look for a downstream 
negative element (ONE) inside the 3' LTR of HTLV-I , as this is where the HTLV-1 positive element 
(RxRE) is situated.
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Observation Two: MLV extended psi sequence overcomes the CRS-mediated repression
Removal of the MLV extended psi sequence from the two constructs, revealed a difference in Tax- 
induced CAT expression between constructs containing and lacking the CRS. Therefore, the psi 
sequence appeared to have overcome the nuclear retention of the full length construct and to 
enhance expression in the CRS" construct. From MLV sequence data (Weiss et al. 1985), there 
were no known splicing signals present, suggesting that a positive element existed which was 
capable of promoting the transport of transcripts from the nucleus to the cytoplasm. Such a 
sequence termed CTE (constitutive transport element) had been recently described (Bray et ai. 
1994) to be present in the Mason-Pfizer Monkey Virus (MPMV). When inserted into a Rev- 
dependent HIV envelope expression plasmid, it resulted in the removal of Rev dependency. HIV 
eov transcripts are normally trapped in the nucleus until HIV Rev protein binds to the transcript's 
Rev response element (RRE) allowing it to leave the nucleus.
The next series of experiments (SECTION B) was carried out in order to explain how the MLV 
extended psi sequence was able to remove the Rex dependency of the HTLV- I CAT constructs. 
Experiments aimed at locating the downstream negative element (ONE) will be described later in 
SECTION C.
Results 56
SECTION B: Presence of a CTE inside the MLV Extended Packaging Sequence  
• Re-introduction of Psi Fragments
Initially, it was important to determine whether the psi effect was due to a sequence specific 
element, - such as a CTE - or whether the effect seen was size dependent. RNAs with longer 5' 
non-translated regions may tend to be more stable (Muhlrad et al. 1994, 1995). To differentiate 
between the two possibilities, it was decided to re-insert fragments of the 872bp psi sequence 
back into the J258 construct. However, since the Hind III site had been destroyed in J258, it was 
first necesary to re-introduce a Hind III site via site-directed mutagenesis (SDM). This was done in 
the J245 construct to create a new Hind III site between the end of the S' LTR and the beginning if 
the psi sequence. The S' phoshorylated Hind III insertion (#109) and Kpn I deletion (#108) oligos 
were annealed to the same single strand of template DNA. The oligos were extended and joined to 
one another by DNA pol I. The product was digested with Kpn I, phenoLchloroform extracted, 
ethanol precipitated and used to transform E.Coli (strain XLI-blue). Resulting colonies were then 
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Figure 16. Introduction of a Hind I I I  site to enable removal of the psi sequence as a 
Hind H I fragment. Site-directed mutagenesis (using Stratagene's Chamaeleon® kit) was 
performed to introduce an additional Hind III site into construct J245. The two SDM  
oligonucleotides are described in the materials section. The 872 bp psi sequence was then 
removed and cloned into Bluescript for subsequent modifications (J304). Following psi 
removal, the vector was allowed to re-circularize (via Hind 111 ligation) to produce construct 
J296b. This was identical to J258 except for the presence of the new Hind III downstream of 
the 5' LTR.
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Re-insertion of tfie entire psi sequence in the reverse orientation (construct J296a) led to complete 
loss of CAT activity, probably due to the presence of complex secondary structures. The possibility 
that the loss of CAT activity was due to mutations in the CAT gene during SDM was checked by 
comparing the CAT expression from SDM-derived constructs (J296b & J292) to those which did 
not undergo SDM (J258 & J245). Results confirmed that the SDM process was not responsible for 
the loss of CAT expression (fig. 17).
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Figure 17. CA T assay to compare expression of SDM-derived and normal constructs.
Jurkat cells were transfected with 5pg of each CAT plasmid. 48hrs after transfection, lysates 
were prepared, standardized for total protein and assayed for their CAT activities. Comparison 
of the SDM-derived constructs (J296b and J292) to normal constructs (J258 and J245) showed 
that no damaging mutations had been introduced by SDM and that this was thus not 
responsible for the zero CAT expression seen in construct J296a. Percentage conversion of 
chloramphenicol (boxed) is shown .
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The 872bp psi sequence, once cloned into the Bluescript II plasmid, contained two unique cloning 
sites. 201 bp inside the 5' end of the psi sequence was an Aat II site and 312bp from the 3' end was 
a BstE II site. Construct J304 was cleaved using Aat II, Klenow blunted and ligated to Hind III linkers. 
In parallel, another small amount of construct J304 was cleaved with BstE II, blunted and had Hind III 
linkers ligated to the blunt ends. Now the 872bp psi fragment could be cleaved by Hind III to yield 
either 201 bp and 671 bp fragments or 560bp and 312bp fragments. Each of the four fragments 
was ligated independently into the Hind III site of construct J296b (fig. 18).
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Figure 18. Linker insertion into psi sequence followed by cloning of psi (Hind I I I )  
fragments into the SDM construct J296b. The new constructs containing the 201, 312, 560 
and 671 bp psi fragments in the positive orientations were checked by sequencing and then 
named J329, J330, J325 and J326, respectively.
These constructs were then used to transfect Jurkat T cells. Lysates were made and assayed for 
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Figure 19. C A T expression assay of psi fragment containing constructs. 5pg of each of 
the four new constructs was co-transfected with Tax and Rex expressing plasmids. Lysates were 
prepared, standardized for total protein and assayed for their CAT activities. These were 
compared to the psi" construct (upper row, lanes 1-3) and to the construct containing the full 
872bp psi sequence (lower row, lanes7-9). % maximum acétylations were calculated for each 
construct, taking the Rex induced level as the maximum in each case. * The high %  of 
maximum is due to the unusually low figure after rex induction.
From this experiment it was seen that the CTE effect was not size dependent but localized to the 3' 
end of the psi sequence, within the terminal 312bp. To rule out the possibility that the CTE effect 
was specific to human T cells, constructs containing psi 312 and psi 560 fragments were used to 
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Figure 20. C A T assays repeated in COS7 and Hela cells. The psi 312 and psi 560
containing constructs were compared to the psi" construct. These transfections were carried out 
using 15pg of CAT reporter plasmid and 5|ig of Tax expressing plasmid. Lysates were 
prepared 48 hours after transfection, standardized for total protein and assayed for CAT activity.
The pattern was similar in all three cell lines, showing the CTE to be present in the 312 bp fragment 
of the extended psi sequence. CAT expression levels from C0S7 cells were seen to be lower than 
from Hela cells. This was due to the high transfection efficiency of the Hela cells relative to C 0S7 in 
this experiment. To further enhance expression levels from C 0S7 transfected constructs, the 
SV40 origin of replication (ORI) was inserted into all plasmids of interest. SV40 large T antigen, 
which is present in COS cells acts to stabilize SV40 ORI containing plasmids in the nucleus as 
episomes. Expression from episomes yields a larger number of transcripts, which is important when 
analyzing the size and intracellular location of the RNAs.
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• PCR Subcloning of the SV40 Origin of Replication
%








S a l l / X h o l




Figure 21. PCR amplification and cloning of the SV40 O R I. Oligos (#116 &  117) were 
designed to amplify the SV40 ORI sequence from plasmid pL.SEAP (Berger et al. 1988) (A). 
The numbers relate to positions in the SV40 virus. Primers were chosen to anneal at 
approximately the same temperature and introduce two compatible restriction sites for 
convenient cloning into the Xho 1 site, just upstream of the 5' LTR in all H T LV -I based 
constructs (B). Clones having a single ORI insert in the negative orientation, relative to the 
HTLV-1 promoter, were selected via PCR screening of colonies and verified by DNA  
sequencing (T7 primer).
COS cells were originally immortalized by the SV40 large T antigen (Gluzman, 1981). The presence 
of SV40 large T enables cells to maintain SV40 ORI-containing plasmids as episomes in the 
nucleus. Expression from episomes results in more transcription which is useful when specific 
RNAs are to be visualized or isolated and purified. The 94bp PCR fragment was inserted into the 
Xho I site of three constructs which were used to examine the role played by the psi CTE .
Constructs 
Full Length 
Full length + psi312 
Full length + psi560








Table 1. Change of plasmid nomenclature upon insertion of the SV40 O R I sequence.
Having shown that CAT expression was increased upon introduction of the psi 312 fragment into 
the full length construct, it was important to determine at which level the regulation was taking place.
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The element could have been acting to increase the level of transcription or induce a cryptic 
splicing event. Splicing involving the 5'LTR splice donor and a cryptic splice acceptor within the psi 
312 region would have resulted in splicing out of the CRS element from the 5' LTR. To determine 
whether either of these two mechanisms was responsible for the psi 312 effect, mRNA was purified 
from C 0S7 cells that had been transfected with either the full length (J337) or psi 312 (J339) 
constructs. The RNA was blotted on to a membrane and probed first with a 32p.|abelled CAT probe 
and then with a glyceraldehyde-6-phosphate dehydrogenase (GAPDH) probe as a control for the 
amount of cellular RNA present.
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Figure 22. Northern blot of mRNAs obtained after transfection of COS? cells with 
constructs J337 and J339. A GAPDH probe was used to allow standardization of the relative 
amounts of CAT specific mRNAs.
From the Northern blot it was clear that insertion of the psi 312 fragment did not lead to an increase 
in the steady state level of mRNA. The mRNA band from the psi 312 construct (fig.22 lane 3) was 
observed at the expected height, indicating that splicing had not occured.
To test whether the presence of the psi 312 fragment led to transport from the nucleus to the 
cytoplasm it was important to be able to visualize the specific CAT mRNAs within the transfected 
COS 7 cells. By using the fluorescence in situ hybridization (FISH) technique, it was expected that 
CAT RNAs would be visible intracellularly.
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• Fluorescence In-Situ Hybridization - Determination of CAT mRNA location
Here, a small number of cells (100,000) were seeded on glass microscope slides and Calcium 
Phosphate transfected. The cells were then fixed and partially permeablized. Biotin-dUTP labelled 
probe (single-stranded DNA) was then allowed to enter the fixed cells and hybridize to the RNA 
molecules. After washing away non-hybridized probe, fluorescein- tagged avidin was then used to 
detect the RNA-DNA complexes. Cells were examined under the fluorescence or LSM microscope 
(Zeiss) using a 40x or 63x lens to determine in single cells the localization of specific RNA .
Initially , the FISH experiment was tested on mouse NIH3t3 cells that had been stably transfected 
with a p-galactosidase expressing construct (RSV-LacZ). Here it was expected that the (3- 
galactosidase RNA would be present in the cytoplasm of all cells.
Figure 23. FISH of (3-gaIactosidase expressing N IH3t3 fibroblasts. Here cells were seeded 
onto glass slides and allowed to become sub-confluent. After being fixed and permeablized, the 
cells were probed with biotinylated-dUTP labelled LacZ probe. After washing to remove non­
hybridized probe, fluorescein-tagged avidin (green) was added to detect LacZ RNA-DNA  
hybrids. A short incubation with propidium iodide (PI) was then made to visualize the cell 
nuclei (red).
Although the FISH worked, it was decided to switch from biotinylated-dUTP to Digoxoginin-11- 
dUTP as it was observed in non-transfected cells that the small amount of endogenous biotin 
present was causing a faint cytoplasmic background signal.
Next, to determine whether or not a clear distinction could be made between a nuclear localization 
and a cytoplasmic localization, the full length (ORI-containing) construct (J337) was used.
It had been shown that upon Tax co-expression alone, a full length construct yielded almost no 
CAT protein. The additional expression of Rex was required for CAT activity. In this situation, J337 
RNAs should be visible in the nucleus in the absence of Rex and in the cytoplasm in the presence 
of Rex. The full length (J258) construct was used to make a labelled probe via the nick-translation 
reaction (see methods section). CCS7 cells were chosen in combination with plasmids containing 
the SV40 CRI element.
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Figure 24. FISH to optimize nuclear/cytoplasmic staining in COS7 cells. Fluorescense in- 
situ hybridization of dUTP-DIG labelled, CAT-specific probe to CAT RNAs inside transfected 
C0S7 cells. Cells were either co-transfected with Tax plasmid (A) or Tax & Rex plasmids 
(B). Propidium Iodide (PI) was used to stain the nuclei (red). A fluorescein-tagged anti-DIG 
antibody (green) was used to detect the labelled probe. Where the antibody had a nuclear 
localization, the product fluorescence was yellow. The dark red structures visible inside the 
yellow nuclei are the nucleoli.
Here it was possible to clearly distinguish between nuclear and cytoplasmic localizations of CAT 
RNA.
It was then possible to transfect the psi 312- and psi 560- containing constructs and compare their 
localization to the full length (psi ') construct and the psi 872 containing construct.
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Figure 25. FISH analysis of COS7 cells transfected with psi fragment constructs.
Fluorescense in -s itu  hybridization of CAT probe to RNAs present in COS? cells after 
transfection with the full length psi" J337 (A), the psi 312- containing J339 (B), the psi 560- 
containing J340 (C) and the psi 872- containing J245 (D) constructs. Specific CAT RNAs 
were detected by fluoresein-tagged anti-DIG antibody (green). Cell nuclei were stained by short 
incubation with PI (red).
It is clear that the psi 312 and psi 872 cis-sequences led to CAT expression by allowing the 
transcripts to leave the nucleus. The 560bp psi fragment did not allow CAT protein expression, 
because the transcripts were still mainly trapped in the nucleus. To obtain a statistically sound 
quantitation of the shift in expression from the nucleus to cytoplasm upon "psi CTE" function, over 
200 transfected cells per transfection were counted and scored as having either nuclear or 
cytoplasmic RNA localizations. The ratio of cytoplasmic localizazions to nuclear localizations was 
calculated and plotted for each construct.
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Ratio of cytoplasmic:Nuclear staining
Figure 26. Analysis of the distribution of CAT RNA between nucleus and cytoplasm.
This was expressed as a ratio of cells with cytoplasmic to those with a nuclear localization of 
CAT RNA. Short bars denote nuclear localization - long ones, cytoplasmic. The dotted line 
marks the equal distribution point (1:1). The total number of transfected cells scored for each 
transfection is shown in the right hand column.
Mapping of the psi 312 fragment to the MLV genome
























extended psi sequence (psi 872
psi 560 1037
psi 312
Figure 27. Schematic mapping of the psi 312 fragment to the M L V  sequence. Nucleotide 
(nt) no.l is capped. M LV genome information was taken from "RNA Tumour Viruses" (Weiss 
et al. 1985). The shaded region from nt. 212-563 is the region required for packaging (psi). 
The extended psi (psi"*") allows enhanced packaging, extending to nt. 1037.
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Nuclear export of cellular and viral RNA has, in many cases been shown to be mediated by RNA 
binding proteins which in turn bind nucleoporin-like proteins (Gorlich and Mattaj 1996). Competition 
experiments have shown that although different classes of RNA molecule are bound by specific 
RNA binding proteins, the array of transport-mediating nucleoporins could be more limited. To 
determine whether or not the psi312 RNA is bound by a cellular factor, three new plasmids were 
constructed.
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Figure 28. In vitro transcription constructs. The psl201 and psl312 Hind III fragments were 
ligated into the Bluescript plasmid at the Hind III site (J333A and J334A, respectively). The 
RxRE was ligated into Bluescript as an EcoRI fragment (J335A). This fragment was PGR 
amplified as described in SECTION C fig. 36. All three insertions are in the positive 
orientation with respect to the T7 promoter.
Constructs J333A, J334A and J335A were made to allow the production of radio-labelled RNA 
transcripts via in-vitro transcription from the T7 promoter. J333A was designed to be a negative 
control as the psi201 fragment did not lead to an increased CAT activity. Construct J335A was 
designed to be a positive control for binding. In this case, a Rex expressing plasmid would need to 
be co-transfected.
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The labelled RNAs could be used in two different ways to detect a specific binding protein. Firstly, a 
"gel mobility assay" or "band-shift" experiment could be carried out using nuclear extracts. Binding 
of a cellular factor would result in a retardation of the labelled RNA on a polyacrylamide gel. In this 
case RNase inhibitors would need to be used to protect the labelled RNAs from degradation. To 
avoid problems associated with RNase digestion, North-Western analysis could be carried out. For 
this the nuclear extracts would be run on a protein gel, blotted onto a membrane and re-natured. 
This membrane would then be probed using the labelled transcripts. A specific binding protein 
would be visualized as a clear band.
Results 69
SECTION C: Identification of a Second CRS 
• Presence of a Second Cis Repressive Sequence - inside the 3'LTR
To address this question, an SV40 polyadenylation signal was cloned in place of the 3' LTR in the 
full length construct (J258). The resulting construct 510 (fig.29) was thus expected to express 
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Figure 29: 755.CAT.poly(A) construct, used to look at the importance of the downstream
NTR. This was cloned by removing an 850 bp Xho I - EcoRI fragment from construct J258 
and cloning it into the Xho I - EcoRI sites of plasmid pBL-CAT 2.
Because transcripts derived from construct 510 would no longer contain a Rex response element 
(RxRE) it was expected that they would no longer be Rex inducible. As changes made did not 
effect the Tax response element (TRE) in the 5' LTR, it was expected that 510 would remain Tax 
inducible. The presence of a negative element inside the 3' LTR would be indicated in a CAT assay 
if - upon removal of the 3' LTR - CAT expression was seen to become less Rex- dependent (ie. CAT 
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Figure 30: C A T assay to examine the role of the downstream non-translated region.
Jurkat T cells were DEAE-dextran transfected with 3 pg of either construct J258 (lanes 1-4) or 
construct 510 (lanes 5-8). Tax and Rex expressing plasmids were co-transfected as indicated. 
Lysates were prepared, standardized for total protein and assayed for CAT activity.
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Removal of the 3' LTR not only reduced the Rex-inducibility, but also partiallv removed Rex- 
dependencv of the transcripts produced following Tax expression (compare lanes 3 & 7). This 
raised the possibility that, as well as a positive regulatory element (RxRE), there could be a 
Downstream Negative Element (ONE) - with similar function to that of the 5' CRS - present in the 3' 
LTR.
Although the Rex induction was dramatically reduced, it was not completely removed upon removal 
of the RxRE-containing 3' LTR. Before the addition of Tax, Rex was able to give a 3- fold increase 
over the background CAT expression for both J258 and 510 (lanes 2 & 6). The Rex-inductions in 
the presence of Tax were different. The full length construct (J258) gave a 125- fold increase, 
whereas, the Rex induction from the 3'LTR-deleted construct (510) is only 2- fold.
Having shown that removal of either the 5' CRS or the 3' LTR led to a partial release of repression, 
we expected the removal of both elements to result in a larger release, and perhaps to a complete 
release from repression. To test this, construct J281 was made. It has both the 5'CRS and the 
3'LTR deleted.
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Figure 31. The 628.CAT.poly(A) construct (J281) was constructed by replacing the 850 bp 
Xho I - EcoRI from construct 755.CAT.poly(A) (510) by that from construct 628.CAT.LTR  
(J259).
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Figure 32. CAT assay showing the result of 3' LTR- and/or 5'CRS- removal. Jurkat cells 
were transfected with 5pg of each CAT plasmid. Lysates were prepared, standardized for total 
protein and assayed for their CAT activities. CAT acétylations were so high for J281 (CRS" / 
3'LTR" ) that the CAT assay had to be scaled down (5x less lysate in a 30 minute reaction) 
and repeated (lanes 13-16 upper values). % acétylations and % of maximum expression are 
shown for each reaction. % maximum acétylation is calculated relative to the rex induced state. 
*The slight reduction observed in the repression released construct upon Rex expression is due 
to promoter squelching.
Removal of both the CRS and the 3' LTR did indeed lead to a complete removal of repression. The 
2-3 fold rex induction seen in the 3' LTR construct (fig 32. lanes 9-12) is no longer seen when the 
CRS is deleted (fig 32. lanes 13-16) suggesting that either the putative Rex-binding motif within the 
5' LTR has been destroyed or that upon removal of both the CRS and the 3' LTR there are no 
repressive sequences remaining and the transcripts are free to be expressed Rex-independently.
• Narrowing the search to the R region of the 3'LTR
Brighty and Rosenberg (1994) reported that the HIV Rev response element (RRE) contains 
sequences which confer Rev dependency. Removal of the RRE was shown to lead, not only to the 
removal of Rev inducibility but also to the removal of Rev dependence, meaning that transcripts 
were able to leave the nucleus without first being bound by Rev. The HIV RRE, in contrast to the 
RxRE of HTLV-I, is present inside the coding region of the HIV env gene.
Prompted by these findings for the HIV RRE, a deletion was made, which specifically removed the 
RxRE from the 3'LTR.
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• Specific Removal of the RxRE from the 3'LTR
Two pairs of primers (#93 & 105 and #106 & 107) were used to PCR amplify the U3 region and U5 
regions separately (see materials section for oligo sequences). The PCR products were cut with 
restriction enzymes and cloned back into the source plasmid via a 3 - fragment ligation, in place of 
the 3' LTR. Care was taken to leave both the poly A signal and poly A site (at either end of the 
RxRE) intact and also to maintain the same "physical" distance between the two elements. The 
sequence between the two elements was, however, mutated to introduce an Xba I site in 
preparation for the possible re-introduction of partial RxRE sequences, later on. The resulting 
plasmid was tested using restriction enzymes. It was found that the introduced Xba I site contained 
a dam methylated sequence and could, therefore, not be cleaved by Xba I. This problem could be 
partly overcome by transfecting either the DNA or ligation mix into a dam methylase free strain (E. 
Coli strain JM101).
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Figure 33. Specific removal of the RxRE via 2 PCRs and a 3-fragment ligation.
Construct J258 was cut with Bam HI and Sac I to remove the 3' LTR. The two PCR products 
(U3 and U5) were cut with enzymes Bam HI &  Xba I and Xba I &  Sac I, respectively before 
being ligated with the large J258 fragment overnight at 16°C. Mini-prep DNA was sequenced 
to ensure that no PCR mis-incorporations had been made.
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The resulting construct 755.CAT.U3 / U5 (J297) was cut with restriction enzymes EcoRI and Sac I to 
remove most of the CAT gene and all of the new 3'NTR. This fragment was then cloned into the 
LTR628.CAT.LTR in place of the 3' LTR (EcoRI - Sac I) to create a construct with the CRS as well as 
the RxRE deleted (construct J294). These two constructs were then transfected into Jurkat cells, 
which were then processed for CAT assays.
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Figure 34: Effect of RxRE removal upon Rex dependency and Rex inducibility. Jurkat 
cells were transfected with 5pg of each CAT plasmid. Lysates were standardized for total 
protein and assayed for CAT activity. Constructs J301 and J300 were made by cloning a CAT- 
poly(A) Hind III  fragment from the plasmid pBL-CAT2 in place of the normal CAT cDNA 
(Hind III - Bgl II). These were used as controls, similar to constructs which lack the 3'LTR 
completely (510 and J281 respectively).* As fig. 35.
This experiment was repeated using the same CAT constructs and Jurkat cells but this time using
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Figure 35. Effect of RxRE removal upon Rex dependency and Rex inducibility. Repeat 
of previous experiment using 3'LTR-deleted plasmids as controls (510 & J281). * This value 
is above 100% because the squelching effect observed upon addition of Rex and Tax expression 
plasmids.
From these experiments, it was clear that removal of the RxRE led to a removal of Rex dependency, 
indicating that the presence of the RxRE indeed had a repressive influence upon CAT expression. 
Interestingly, the increase in CAT activity upon removal of the RxRE was similar to that seen 
following the removal of the CRS. Also, removal of both the CRS and RxRE led in both cases to a 
more than cumulative increase in CAT expression. However, RxRE removal did not result in the 
same level of release as did removal of the complete 3' LTR (see controls J301 & J300 and 510 & 
J281), hinting that the negative element present in the 3' LTR could extend upstream, into the U3 
region.
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• Specific Insertion of the RxRE
If a DNE is present as part of the RxRE, then it should also function outside the context of the 
HTLV-I LTR. In work done by Seiki et al. (1988) in which the positive regulation, mediated by the 
RxRE was described, it was noticed that RxRE introduction led to a reduction in basal CAT 
expression. However, this observation seems to have been overlooked. To examine this more 
carefully, the RxRE was PCR cloned using oligos #113 and 114, and inserted just upstream of the 
SV40 poly A signals in constructs 510 and J281.
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Figure 36: PCR cloning and insertion of the RxRE. This was inserted just upstream of the 
SV40 poly A signal in construct 510. The PCR product was cut with EcoR I and inserted into 
the Mun I site next to the poly A signal to give construct J320A. The same PCR fragment was 
also cloned into construct J281 to give the CRS" variant (J331).
Constructs J320A and J331 were obtained following insertion of the RxRE into constructs 510 and 
J281, respectively. As the RxRE element insertion was not a directed cloning, both orientations 
were obtained. Constructs containing the negative orientation (J320B & J332) were also examined 
for their influence upon CAT expression. These were then used along with the parental constructs 
to transfect Jurkat T cells. Lysates were made and assayed for their CAT activities.
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Figure 37. C A T assay to compare the different RxRE deletions and insertions.
Constructs in the upper panel all contain the CRS. Constructs in the lower panel have the 
CRS deleted. Removal of the RxRE (J297 & J294) or 3'LTR (510 &  J281) was compared to 
the constructs containing a full 3'LTR (J258 & J259). Insertion of the RxRE into the 3'LTR" 
constructs in either the positive orientation (J320A & J331) or the negative orientation (J320B 
&  J332) was compared to the 3'LTR" constructs (510 & J281). Percent acétylation values and 
% maximum expression values (max. acétylation of 100% with Tax and Rex) are shown for 
each reaction. * High value is partly due to squelching.
Insertion of the RxRE in either the positive or negative orientation led to a 3-4 fold reduction in CAT 








Figure 38. Result of RxRE insertion / Deletion on CAT activities in COS? and Hela cell 
lines. Cell lines were transfected with the full length construct (lane 1), the RxRE-deleted 
construct (lane 2), the 3'LTR-deleted construct (lane 3) and the 3'LTR-deleted construct having 
the RxRE re-introduced (lane 4). A Tax expressing plasmid was co-transfected in each case.
The same pattern was seen in all three cell types. Of the two adherent cell types, the clearest 
differences were seen in the C0S7 cells. Five constructs were modified via insertion of the SV40 
ORI element just upstream of the 5'LTR (see section B for cloning details).
The 94bp PCR fragment was inserted into the Xho I site of five constructs which were used to 



















Table 2. Change of plasmid nomenclature upon insertion of the SV40 O R I sequence.
It has been shown in CAT assays that the full length construct (J258) was highly Rex-dependent 
and that this dependence could be partially or completely removed by the various deletion / 
insertion mutations (see figures 34, 35 and 36). It was decided to examine the level of this 
regulation.
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It has been suggested that the presence of the 5' CRS traps transcripts in the nucleus and that 
binding of the HTLV- I Rex protein to the 3' end of transcripts overcomes the block, allowing 
transcripts to enter the cytoplasm (Seiki et al. 1990). We wanted to determine whether removal of 
the above mentioned sequences of interest would indeed lead to a shift in CAT RNA distribution 
between the nucleus and cytoplasm, or whether they were acting via other mechanisms. It was 
decided to analyze the location of CAT RNA via Fluorescence In-Situ Hybridization.
• Fluorescence In -s i tu  Hybridization (FISH)
It was shown in section B, that the FISH protocol worked (fig. 21) and that a clear difference could 
be seen between nuclear and cytoplasmic localizations of specific mRNAs (fig. 22). The 
background staining of the anti-digoxinin antibody was seen to be very low indeed in the non­
transfected COS 7 cell control (fig.39A).
Figure 39. F ISH  of non-transfected COS cells (A) and COS transfected with the full 
length (J337), ORI-containing construct (B). Here the fixed cells were permeablized and 
probed with digoxoginin-11- dUTP which was detected by a fluorescein-tagged anti-DIG 
antibody (green). Propidium iodide was used to stain the nuclei (red). The fluorescent product 
of green and red is yellow.
Transfection conditions were optimized for the full length construct (J337) and the CRS'/3 'LTR ‘ 
construct (J343) in COS7 cells on glass microscope slides. Three different amounts of CAT 
reporter were used (5, 10 and 15 p g ) .  Cells were harvested either 2, 3 or 5 days after transfection 
(To prevent cells becoming too dense, different cell numbers were plated out the day prior to 
transfection). Optimal conditions were found to be: 15 p g  CAT plasmid, 5 p g  Tax expressing 
plasmid and I p g  Rex expressing plasmid (when required). The standard BES transfection protocol 
(see methods section) was applied and the cells harvested 3 days post-transfection. It was seen to 
be very important to use cells that had not been in culture for too long (more than 2 months after 
thawing).
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Figure 40A. FISH of COS 7 cells transfected with the full length (J337) construct and 
theTax expressing plasmid. Cells were harvested 3 days after transfection. The marked cell 
(white arrow) magnification (boxed) was made at a lower fluoresein sensitivity to enable more 
specific intra-nuclear visualization.
Constructs containing the various combinations of CRS and DNE deletions and insertions were 
then used to transfect COS 7 cells and examined using FISH to determine the function of the 
various elements with respect to the preferential localization of CAT RNA.
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Figure 40B-G. FISH of COST cells after transfection with 15 pg of constructs J338 (B), 
J343 (C), J341 (D), J294 (E), J342 (F) and construct J320A (G). All transfections included 
5 pg Tax expressing plasmid. Cells were harvested three days after transfection then fixed, 
permeablized and probed with DIG-labelled dUTP probe. This was then detected by 
fluoresein- tagged anti-DIG antibody (green). PI was used to stain nuclei red.
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The degree of cytoplasmic or nuclear staining for each transfection was quantitated. For this more 
than 200 transfected cells per transfection were counted and scored for exhibiting either nuclear or 
cytoplasmic distribution of CAT mRNA. The results for each transfection were then expressed as a 
ratio of nuclear to cytoplasmic staining and plotted together to allow comparison (fig. 41).
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Figure 41. Quantitation of nuclear : cytoplasmic staining ratios. Longer bars indicate 
more nuclear staining. The full length construct (A) showed very high nuclear staining, RNA 
being trapped in the nucleus. Removal of the 5'CRS (B) led to a clear reduction in repression. 
Removal of both the CRS and the 3' LTR (C) led to a complete release, indicated by almost 
complete cytoplasmic staining. Removal of the 3' RxRE alone (D) led to an even larger release 
than removal of the CRS. An additional effect was seen upon removal of both the CRS and the 
RxRE (E). Removal of the 3' LTR (F) led to an even larger release than either removal of the 
CRS or RxRE, again hinting that the negative element could extend into the U3 region. Re- 
introduction of the RxRE into the 3'LTR" construct led to a shift back in the direction of 
nuclear localization, indicating that the level of repression had increased.
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Rex regulation of HTLV-I is mediated via positive and negative elements in both 
long term inal repeats
A downstream negative element (DNE) within the 3' LTR
Rex has been shown to function posttranscriptionally in promoting the expression of HTLV-I 
unspliced and partially spliced transcripts (Inoue et al. 1986b, 1987). To be Rex inducible, a 
transcript must possess the Rex response element (RxRE) and a 5' splice donor site (Seiki et al. 
1988). From our work and that of Seiki et al. (1990), it is clear that the transcript must also encode a 
c/s-repressive sequence (CRS) which - most likely via interaction with some cellular factor(s) - 
represses posttranscriptional processing of CRS-containing transcripts. Seiki et al. (1990) have 
reported the presence of a CRS within the U5 region of the HTLV-I 5' LTR. Similarly, Black et al. 
(1991) identified a CRS element within the U5 region of the HTLV-I I 5' LTR. It has been proposed 
that these CRS elements prevent transcripts from exiting the nucleus. Seiki et al. (1990) made a 
series of U5 and R region deletions in an HTLV-I 5'LTR-CAT expression construct. Deleting the U5 
region from bp 734 or bp 701 to the end of the U5 (bp 755) resulted in no significant increase in 
CAT activity. Northern blot analysis of CAT mRNA showed that following these two deletions, CAT 
mRNA was not observed in the cytoplasm. A larger deletion from bp 620 to bp 755 resulted in a 
very significant increase in CAT expression and cytoplasmic CAT mRNA. Deletion from bp 585 to 
bp 755 resulted in no further increase in CAT expression. Deleting further upstream than bp 585 
led to a major reduction in CAT expression. This is because the R region enhances transcription in 
the context of the HTLV-I LTR promoter (Takebe et al. 1988). As a result of these experiments, it 
was concluded that a CRS existed between bp 620 and bp 701. The appearance, shown by 
Northern blots, of CAT mRNA in the cytoplasm upon CRS deletion suggested that CRS-containing 
transcripts are trapped in the nucleus. We have shown that specific deletion of this CRS did not 
result in the complete removal of Rex dependency (fig. 15). These CAT assay results were 
supported by FISH experiments which showed that CRS removal led only to a partial release of CAT 
mRNA from the nucleus (fig. 408 & 418). It was clear that present within one of the LTRs was a 
second CRS.
Brighty and Rosenberg (1994) showed that present within the same region of the HIV envelope 
gene as the Rev response element (RRE), is a c/s-negative element. Removal of this element 
resulted in the Rev independent expression of HIV envelope and HIV viral replication. Their 
experiments were carried out using Drosop/i/7a cells in which unspliced HIV transcripts are retained 
in the nucleus in the absence of HIV Rev (Ivey-Hoyle and Rosenberg 1990). This aggreed with the 
results of Huang et al. (1991). A CRS within the HIV RRE was also reported by Rosen eta l. (1988) 
and Nasioulas et al. (1994). The HTLV-I RxRE is encoded by the S' LTR. We have shown that 
deletion of the S' LTR leads to a very significant reduction in Rex dependency, indicating that a
Discussion 87
negative element had been removed (fig. 32). Deletion of both the 3' LTR and the 5' CRS resulted 
in a complete release from Rex dependency (fig. 32).
Narrowing the search down, we showed that a significant reduction in Rex dependency resulted 
from deletion of the RxRE (fig. 34 & 35). Transcripts lacking the RxRE were, however, still more Rex 
dependent than those lacking the entire 3' LTR, indicating that the downstream negative element 
(DNE) must extend into the U3 region. Insertion of the RxRE into plasmids lacking the 3' LTR 
resulted in a significant elevation of Rex dependency (fig. 37). Insertion of the HIV RRE was seen in 
some experiments to have no effect on the construct's Rev dependency (Chang and Sharp 1989). 
The authors explained this by suggesting that the CRS function of the RRE was context 
dependent. However, Nasioulas et al. (1994) demonstrated that RRE insertion did lead to an 
increase in the Rev dependency, even outside the context of the env transcript (Zolotukhin et al. 
1994a). Analysis of fluorescence in-sItu hybridization (FISH) experiments showed that removal of 
the RxRE had a similar effect to removal of the 5' CRS, namely a shift in CAT mRNA localization from 
the nucleus to the cytoplasm (fig. 40/41D & E). Insertion of the RxRE into a 3' LTR deleted 
construct (510) resulted in a significant shift back towards a nuclear localization (fig. 40/41G). In 
FISH experiments, as in CAT assays, complete removal of Rex dependence was only observed 
when both the 5' CRS and the complete DNE were removed (fig.40/41C). Brighty and Rosenberg 
(1994) showed via Northern blots of nuclear and cytoplasmic mRNA, that the RRE-containing env 
gp160 RNA was retained in the nucleus in the absence of Rev. Also they showed that Rev function 
did not depend upon the presence of HIV splice sites. Nasioulas et al. (1994) also demonstrated 
that HIV splice sites were not required for Rev function. However, because they extracted total 
RNA, they were not able to show that the RRE CRS was functioning via nuclear retention. Nasioulas 
et al. (1994) demonstrated with their discovery of a second CRS within the HIV env transcript, that 
CRS elements could be species specific. This new CRS, situated within the gp120 region of the 
env  transcript, was functional in human cell lines but not in Drosophila cells. We showed that the 
HTLV-I DNE functioned in the human Hela and Jurkat T cell lines as well as the simian COS 7 cell 
line (fig. 38).
A bone of contention between HIV researchers is the significance of splicing as part of Rev's 
function. In vivo. Rev expression undoubtably results in an increased ratio of unspliced to spliced 
viral transcripts. However, Rev binding has also been linked to subsequent processing steps such 
as nucleocytoplsmic transport, stabilization of cytoplasmic transcripts and enhanced ribosomal 
loading. It has been suggested by two research groups that active splicing or recognition of splicing 
signals is essential for Rev function (Chang and Sharp 1989; Lu et al. 1990; Hammarskjôld et al. 
1991, 1994). Chang and Sharp (1989) used used a p-globin-RRE fusion and reported that 
mutation of both 5' and 3' splice sites resulted in attenuation of Rev function. Hammarskjôld et al. 
(1991) used a p-globin 5' splice site - HIV env construct which contained the env 3' splice site. They 
reported that mutation of the 5' - but not the 3'- splice signal resulted in the attenuation of Rev
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function. Brighty and Rosenberg (1994) suggested that the apparent lack of visible Rev function 
upon mutation of the p-globin splice sites was due to decreased transcript stability. Chang and 
Sharp (1989) cloned the RRE into the second intron of the rabbit p-globin gene. They made point 
mutations of either the 5' or 3' splice sites, or both. Constructs were transfected together with a Rev 
expression plasmid into COS cells. Nuclear and cytoplsmic RNA was extracted and analysed using 
nuclease SI mapping. Rev function was observed as a cytoplasmic accumulation of unspliced 
RNA. This was observed for the non-deleted and the single splice site deleted constructs. 
Unspliced RNA from constructs having both splice sites mutated was seen to accumulate in the 
cytoplasm, independent of Rev function. Rev expression resulted in no further enhancement. The 
authors concluded that recognition of splice sites by the splicing machinery is required for Rev 
function. Brighty and Rosenberg (1994) point out that in the experiments of Chang and Sharp 
(1989), the level of RNA was significantly reduced following splice site mutation and that the result 
of splice site mutation was the destabilization of p-globin transcripts.
It has been reported that expression of p-globin is highly dependent upon its mRNA being actively 
spliced, allowing it to accumulate in the cytoplasm (Hamer and Leder (1979); Hamer etal. (1979). As 
both groups used the p-globin splice donor site, it could be that the observed dependence of Rev 
upon splicing signals was due to the inherent instability of p-globin intron-containing mRNAs.
Brighty and Rosenberg (1994) showed that mutation of the HIV 5' and 3' (env) splice sites did not 
remove Rev responsiveness. In addition, many other groups have reported that neither active 
splicing nor recognition of splice sites is essential for Rev's funtion in promoting the accumulation of 
incompletely spliced mRNAs in the cytoplasm (Felber et al. 1989; Malim etal. 1989; Emerman etal. 
1989; Knight et al. 1987; Rosen et al. 1988). Taken together it seems more likely that the most 
significant function of HIV Rev and HTLV Rex is in overcoming the effects of cis negative elements 
which either retain transcripts in the nucleus (CRS) or destabilize the transcript once in the 
cytoplasm (instability regions). It is still possible, however, that interaction of a 5' splice site- 
containing transcript with the splicing machinery enhances the nuclear retention effect. Our FISH 
results show that the main function of HTLV-I Rex is the nuclear export of CRS-containing 
transcripts (fig. 24 & 40b).
One significant difference between the CRS elements discovered in HIV and HTLV viruses is that 
the HIV CRS elements are located within the coding region, whilst the HTLV CRS elements are 
within the non-translated regions. As well as the two CRS elements shown to exist in the gp41 and 
gp120 regions of HIV env (Brighty and Rosenberg,1994; Nasioulas et al. 1994) there have also 
been reports of an RNA destabilizing sequence (INS-1) within the HIV gag gene (Schwartz et al. 
1992a). This element was found to be AU rich, a feature that mRNAs of short half life have in 
common and which may lead to their preferential deadenylation and nuclear degradation. Efficient 
HIV Gag expression could be obtained either upon addition of Rev or through introducing specific
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mutations within the destabilizing region (Schwartz et al. 1992b). As the HIV env gene has already 
been shown to contain two separate CRS elements, which would be present not only in env  
transcripts but also within gag-pol transcripts, it would seem unneccesary for the gag  gene to 
encode its own. It is possible that the gag CRS (INS-1), which acts to destabilize the RNA acts as an 
extra control mechanism to prevent "leaky" expression of structural genes before the main wave of 
Tat/Rev initiated gene expression. Such a mechanism could allow the virus to "hide" more 
effectively from the host's immune system. It is interesting that Rev is able to overcome not only the 
nuclear retention effect of the HIV env CRS elements but also the RNA destabilizing effect of the 
HIV gag INS element. The HTLV-I 5' CRS appears to function in the same way as the HIV env CRS 
elements, preventing unspliced transcripts from leaving the nucleus. The 3' DNE, also shown to 
inhibit nuclear export of RNA, could be functioning as an extra control mechanism preventing the 
leaky expression of all HTLV-I genes, including the regulatory genes fax and rex. This would be 
expected to result in very low basal expression of the tax gene in HTLV-I infected patients relative 
to the HIV faf gene in HIV infected patients. Indeed it has been reported by Nerenberg et al. (1987) 
that levels of Tax protein expression directed by an HTLV-I based vector system were 
unexpectedly low. This may be due to the apoptotic effects of Tax (Chlichlia eta l. 1995) but also to 
the fact that the 3' LTR was used. The presence of a cis repressive element within the tax and rex 
transcripts could partly explain the difference in latency period between HIV and HTLV.
Cis negative elements have not only been identified in retroviruses. The LI transcript of Human 
Papilloma Virus has been shown to contain two separate RNA "instability" regions (Tan and 
Schwartz 1995; Kennedy e ta l. 1994). These were shown not to inhibit the transport of transcripts 
to the cytoplasm but instead to prevent efficient translation once there. LI expression could be 
restored by inserting the HIV RRE and expressing Rev. The "instability" regions were shown to 
have AU contents of approximately 59%, similar to the 61.5 % reported by Schwartz et al. 1992a, 
1992b) for the HIV gag INS-1. The authors speculate that AU richness may lead to a transcript being 
bound by a cellular factor and transported to a cytoplasmic compartment in which translation is 
prevented.
A Rex response element (RxREI encoded bv the 5' LTR
It is well accepted that Rex functions via binding to the RxRE encoded by the 3' LTR (Seiki et al. 
1988). The sequence and structural specificities of the Rex binding site have been delineated via 
mutagenesis analysis (Toyoshima etal. 1990, Grassmann eta l. 1991). A most unusual observation 
was made when investigating the effect of Rex upon transcripts lacking the 3' RxRE. Rex was 
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Figure 42. 3' RxRE deleted constructs showing different levels of Rex inducibility.
NB. The exact boundries of the DNE within the 3'LTR are not known.
Constructs lacking the 3' RxRE but containing either part of the DNE (J297) or both this and the 5' 
CRS (J294) were seen, reproducibly to be 2-3 and 8-10 fold Rex inducible, respectively (fig. 34 & 
35). 2-3 fold Rex inductions were also observed from constructs (510 and J301) possessing the full 
5' LTR but lacking the entire 3' LTR (fig. 30,32, 34 & 35). Only constructs lacking both the 5' CRS 
and the entire DNE ( J281, J300) were Rex non-inducible (fig. 32, 34 & 35). Initially it was 
suspected that a low level of incorrect termination of transcription at the 5' LTR of our circular 
plasmids was responsible for this apparent artifact. However, Rex inductions were still observed 
after experiments were repeated using plasmids linearized just upstream of the 5' LTR, leading us 
to believe that this was not an artifact (results not shown). The only reasonable explanation for 
these data is that Rex is able, albeit with reduced efficiency, to bind to the Rex binding stem loop 
encoded by the 5' LTR.
In HTLV-I the 3' RxRE is formed and stabilized by the annealing of a stretch of nucleotides just 
downstream of the polyadenylation signal with a stretch just upstream of the polyadenylation site. 
This is referred to as stem A. Because the RNA cap site (nt 306) is within the R region of the 5' LTR, 
the first stretch of nucleotides contributing to stem A (nt 337 to 362) does not exist, and so a 
significant portion of the RxRE is unable to form. However, the Rex binding stem loop is formed by 
nucleotides 506 to 550 and is thus present not only within the full length (755bp) 5' LTR but also 
within the CRS-deleted LTR628. the CRS begining at nucleotide 620. The putative 5' LTR Rex 
















Figure 43, Proposed secondary structure of RNA encoded by the H TLV-I 3’ LTR.
In HTLV-II, two RxREs have been identified. The first is present at the R/U5 boundary of the 5' LTR 
and the second at the U3/R boundary of the 3' LTR. It has been shown that a CRS is present just 
downstream of the 5' RxRE of HTLV-II and that this RxRE is sufficient for Rex function (Black et al. 
1991). The 3' RxRE appears to be redundant. The HTLV-II 5' RxRE is more stable than the 
proposed HTLV-I 5' RxRE because the HTLV-II cap site is upstream of the stabilizing stem A. The 
HTLV-II CRS element identified within the 5' LTR is not repeated in the RNA encoded by the 3' LTR 
as it is downstream of the polyadenylation site. This is also the case for the HTLV-I CRS. 
Remembering that HTLV-I and HTLV-II are very closely related, it would seem likely that a common 
HTLV ancestor was able to bind Rex at both RxREs equally well. HTLV-II then evolved towards a 
greater dependence upon Rex binding at the 5' RxRE, perhaps through a requirement or 
preference for a more direct interaction with the 5' splice donor site. HTLV-I, on the other hand 
evolved towards a greater dependence upon Rex binding at the 3' RxRE. An important 
consequence of this variation is that HTLV-I Rex binding tends to stabilize all three structural genes' 
expressions whereas HTLV-II Rex binding must preferentially stabilize the pagf-po/transcript. Singly 
spliced envtranscripts no longer have the 5' RxRE and can thus only be Rex induced via binding to 
the 3' RxRE. An intermediate situation exists in HIV, where Rev is able to bind both the unspliced 
and singly spliced transcripts, the RRE being present within the envcoding region.
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The presence - in cis  - of a sequence derived from the MLV g a g  gene is sufficient 
to remove the Rex dependency of HTLV-I LTR transcribed mRNAs.
Seiki et a i  (1990) reported that HTLV-I LTR transcribed mRNAs are retained in the nucleus due to 
the presence of a cis repressive sequence (CRS) in the 5' non-translated region. Our own work - 
using Fluorescence in-situ Hybridization to visualize specific mRNAs transcribed by the HTLV-I LTR 
- showed directly that this is indeed the case. We observed that HTLV-I constructs containing the 
MLV extended packaging sequence (psi+) did allow expression of a CAT reporter gene in the 
absence of Rex expression (fig. 12 & 13). Removal of the psi+ resulted in the return of complete 
Rex dependency (fig. 15). Analysis of the psi+ when inserted in the reverse orientation was not 
possible due to the presence of multiple translation start / stop signals. Instead, the psi+ was 
divided up into four different regions, each then being re-inserted in the positive orientation. CAT 
assays using these constructs showed that the observed psi+ effect was sequence specific and 
not merely dependent upon the length of the DNA fragment inserted (fig. 19). A specific psi+ effect 
was localized within the last 312bp of the psi-"- sequence. This region corresponds to the p i 5 
coding region of the MLV gag gene (fig. 27).
Because the observed psi+ effect was similar in nature to the result obtained upon removal of the 5' 
CRS, it was initially suspected that the psi 312 fragment may contain a splice acceptor site. Splicing 
into such a site from the R region splice donor would have resulted in removal of the 5' CRS and 
more efficient expression through having had an intron spliced out. Although there are no known 
splice acceptor signals within the psi 312 fragment, it was possible that a cryptic site was being 
utilized. Recently, Oshima et al. (1996) described cryptic MLV splicing events. These splice sites 
were, however, all downstream of the region corresponding to the psi 312 fragment and were 
shown to be extremely weak. The fact that these weak signals were downstream further supports 
our idea that the psi 312 fragment does not even contain any cryptic splice acceptor sites. Northern 
blot analysis showed that RNA from C0S7 cells transfected with the psi 312 containing construct 
was, as expected, larger than the control construct which lacked the psi fragment (fig. 22). This 
again supported the idea that the observed psi+ effect was not due to splicing out of the 5' CRS 
element.
Fluorescence in-situ hybridization was used to determine whether the psi 312 fragment was able to 
remove the nuclear retention, already seen to exist for transcripts derived from ORS-containing 5' 
LTRs. The presence of either the psi 312 or complete psi (872bp) sequence was seen to produce 
a very significant shift from nuclear to cytoplasmic CAT RNA localization (fig.25 & 26). CAT RNA from 
constructs lacking the psi or containing the psi 560 fragment were seen to be retained in the 
nucleus (fig. 25 & 26).
A common question has always been whether Rex enhances a transcript's expression by inhibiting 
its association with the splicing machinery, promoting its transport to the cytoplasm, stabilizing it
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once in the cytoplasm or through enhancement of the translation process. We have shown that the 
same shift in localization of RNA to the cytoplasm is seen upon insertion of the psi 312 fragment as 
upon Rex enhancement of CAT expression in a construct lacking the psi fragment (fig. 24 & 25). 
This indicated that the major function of the psi 312 fragment in our system is to allow the Rex 
independent transport of CRS containing transcripts to the cytoplasm where they can then be 
translated.
Bray et al. (1994) described a similar phenomenon after inserting a fragment of the Mason Pfizer 
Monkey Virus (MPMV) genome into a Rev dependent, HIV env expression construct. The MPMV 
insertion resulted in the removal of Rev dependency. The authors argue that the 219 bp fragment 
of MPMV (bp 8022-8240) was able to enhance expression of envby promoting the nuclear export 
of env transcripts and thus termed it a "constitutive transport element" (CTE). They proposed that 
CTE recognition by some cellu lar factor(s) could target the RNA-protein complex to a 
nucleocytoplasmic transport pathway, avoiding interaction with the splicing machinery.
Zolotukhin eta l. (1994b) showed that an element from simian retrovirus type 1 (SRV-1) was able to 
overcome the requirement for HIV Rev and the RRE, allowing the continuous propagation of two 
different HIV molecular clones. As mentioned previously, the LI transcript of the human papilloma 
virus contains two instability elements (Kennedy etal. 1991 ; Tan and Schwartz 1995). It was shown 
that although transported to the cytoplasm, they were not translated. The SRV-1 CTE was shown to 
be able to overcome this inhibition, allowing expression of LI protein (Tan et ai. 1995). Bray et al. 
(1994) showed that the MPMV CTE and the SRV-1 CTE share 93% nucleotide composition 
identity. No significant identities were found between the MLV CTE and the CTE elements of 
MPMV and SRV-1. It would seem likely that these two D-type retroviruses utilize a cellular factor to 
promote the transport of their genomic CTE-containing transcripts in a similar way to HIV, HTLV and 
bovine leukaemia virus (BLV), which all encode there own viral posttranscriptional regulators (Rev 
and Rex etc).
Although Rex was no longer required for expression of psi 312 CTE containing transcripts, it did 
further enhance expression. The same observation was made by Bray eta l. (1994), Rev being able 
to further enhance the HIV env expression from the MPMV CTE containing construct. The authors 
suggested that Rev was still able either to stabilize the RNA or "act in concert with the MPMV 
element to accomplish export". The MPMV CTE was also seen to function more efficiently, relative 
to Rev induction alone, in simian CMT3 cells but not in human Chang liver cells, suggesting some 
degree of variation between different cell types. The psi 312 fragment was seen to function in 
human Jurkat T cells, human Hela cells and simian COS7 cells (fig. 20). However, the psi 312 effect 
was not compared to the Rex induction alone for all of the cell lines.
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CTE - possible mechanism of action
Recent investigation of the nuclear export mechanism suggests that RNA molecules are 
transported into and out of the nucleus by specific transport proteins and not as "naked" RNA 
molecules. The model system used to examine the process of nuclear RNA export is that of HIV 
Rev binding to the RRE. It has been shown that neither the RNA alone nor the RNA-Rev complex is 
able to exit the nucleus alone. A cellular factor was required. Two-hybrid experiments performed in 
human and yeast systems - both using the Rev activation domain as "bait" - led to the identification 
of two distantly related proteins termed human hRIP and yeast RIP 1p, respectively (Fritz et al. 
1995, Bogerd et al. 1995, Stutz e ta l. 1995). The interaction of Rev and RIP has been shown to 
depend on a nuclear export signal (NES), present within the activation domain of Rev. Similar NES 
motifs have been identified within nuclear proteins that are known to be exported to the cytoplasm 
(Fischer etal. 1995, Wen eta l. 1995, Fridell etal. 1996).
The psi 312 CTE must therefore either directly bind a nuclear export factor or an NES containing 
protein which then through its NES interaction with a nuclear export factor is exported to the 
cytoplasm. To address this issue, three constructs were made for use in In-vltro  transcription 
experiments (fig. 28). Should the radioactively labelled psi 312 RNA bind a cellular factor, this 
binding would be visualized in a gel mobility shift assay or in a North-western blot analysis. The 
RxRE and psi 201 fragment containing constructs were prepared as positive and negative controls 
for RNA binding.
The discovery of a CTE element within the MLV extended packaging sequence helps to explain 
the observed increase in packaging efficiency upon its inclusion into retroviral vectors. In this case, 
nucleocytoplasmic transport of the vector transcripts is upregulated which indirectly leads to 
increased packaging (Bender et al. 1987). It is thus likely that psi+ sequences do not directly 
mediate the encapsidation / packaging process.
O u tlo o k
The development of new vector systems for use in diverse gene therapy protocols has recently 
been prioritized by the NIH gene therapy review committee . Problems such as low effective virus 
titer, post-integration expression loss and the absence of good inducible expression systems will 
need to be addressed. HTLV-I based retroviral vectors present an alternative to the murine based 
vector systems, offering new perspectives for future vector development.
The HTLV-I LTR, having evolved within the human host may allow a more efficient expression in 
human target cells. Through incorporation of the two cis negative elements (CRS & DNE) and use 
of the non-toxic Rex gene, a gene cloned between the LTRs could be inducibly expressed, control 
being exerted at the posttranscriptional level. It has also been demonstrated that HTLV-I based 
vectors allow the double copy modification through insertion of an expression cassette into the 3'
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LTR U3 region (Aat II site). For more efficient expression of a gene cloned between tfie LTRs in 
both standard and DC vector designs, a 3' splice acceptor site should be inserted immediately 
downstream of the packaging signal to allow the genes expression from a spliced transcript.
The use of constitutive transport elements (CTE) in cis to increase the efficiency of nuclear export 
will allow a further enhancement of vector gene expression. This may be of particular use when 
expressing transcripts which are unstable and readily degraded in the nucleus. As observed for the 
SRV-1 CTE, it is possible not only to enhance nucleocytoplasmic transport but also to enhance the 
expression of AU rich INS instability elements such as HIV-2 vif, c-myc, c-fos, GM-CSF (Jones et ai. 
1987; Rabbitts e ta l. 1985; Shaw e ta l.  1986; Shyu et al. 1989; Triesman 1985; W ilson and 
Triesman 1988).
Before such viruses could be used in-vivo, they would need to be rendered Tax independent. 
Replacement of the Tax response elements in the U3 region of the 3' LTR by a house keeping 
enhancer would render viral transcription Tax independent, following reverse transcription and 
integration into the host's genome. An added benefit from this modification - which would result in a 
reduced nucleotide identity between the two LTRs - is that general (ie. recA independent) 
recombination events in E.Coli would be less likely.
In summary, the development of HTLV-I based retroviral expression constructs has provided 
important insight into the manner in which retroviruses regulate the coordinate expression of their 
genes. Understanding the involvement of viral cis positive and negative sequences enables us to 















CIP Calf Intestine Phosphatase
CREB cAMP response element binding
CRS C/s-Repressive Sequence






DMEM Dulbecco's Modified Eagle's Medium
DMSG Dimethylsulphoxide





EGTA Ethyleneglycol-bis-(b-aminoethyl ether) N,N,N',N'-tetraacetic acid
EtBr Ethidium Bromide
FACS Fluorescence Activated Cell Sorting
FCS Foetal Calf Serum
FDG Fluorescene di-p-D-Galactopyranoside
FISH Fluorescence in-situ Hybridization
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GDP Guanosine Diphosphate
GTE Glucose / Tris / EDTA
GTP Guanosine Triphosphate
HEPES N-2-Hydroxyethylpiperazine-N-2'-ethanosulphonic acid
HIV Human Immunodeficiency Virus
HPLC High Performance Liquid Chromatography
1RES Internal Ribosome Entry Signal
HTLV Human T cell Leukaemia Virus
LB Luria Bertani
LSM Laser Scanning Microscope
MOPS 3-(N-Morpholino) propansulphonic acid
mRNA messenger RNA
MuLV (MLV) Murine Leukaemia Virus
NES Nuclear Export Signal
NF Nuclear Factor
NIH3t3 National Institutes of Health 3t3 Fibroblast cell line




ORI Origin of Replication
PBS Phosphate Buffered Saline





RE Restriction Endonuclease (enzyme)
RNP Ribonucleoprotein
RRE Rev Response Element
RxRE Rex Response Element
RNA Ribonucleic Acid
RT Room Temperature or Reverse Transcriptase
RT-PCR Reverse Transcriptase PCR
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SDM Site Directed Mutagenesis
SDS Sodium Dodecylsulphate
SSC Sait Saturated Citrate
SV 40 Simian Virus 40
TAE T r is /Acetate / EDTA
Taq Thermophilus Aquaticus
TBE Tris / Borate /EDTA
TBS Tris Buffered Saline
TE Tris/ED TA
TELT Tris / EDTA / Lithium Chloride / Triton X-100
TEMED N,N,N',N'-Tetramethylethylinediamine




v/v Volume / Volume
w/v Weight / Volume
X-Gal 5-Bromo-4 Chloro-3-indolyl-p-D-galactopyranoside
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